<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><?covid-19-tdm ?><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">85679</article-id><article-id pub-id-type="doi">10.7554/eLife.85679</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Epidemiology and Global Health</subject></subj-group></article-categories><title-group><article-title>An umbrella review of systematic reviews on the impact of the COVID-19 pandemic on cancer prevention and management, and patient needs</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-301524"><name><surname>Muka</surname><given-names>Taulant</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3235-3073</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-301525"><name><surname>Li</surname><given-names>Joshua JX</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-301526"><name><surname>Farahani</surname><given-names>Sahar J</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-97793"><name><surname>Ioannidis</surname><given-names>John PA</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3118-6859</contrib-id><email>jioannid@stanford.edu</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02k7v4d05</institution-id><institution>Institute of Social and Preventive Medicine, University of Bern</institution></institution-wrap><addr-line><named-content content-type="city">Bern</named-content></addr-line><country>Switzerland</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Meta-Research Innovation Center at Stanford (METRICS), Stanford University</institution></institution-wrap><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Epistudia</institution><addr-line><named-content content-type="city">Bern</named-content></addr-line><country>Switzerland</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t33hh48</institution-id><institution>Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong</institution></institution-wrap><addr-line><named-content content-type="city">Sha Tin</named-content></addr-line><country>Hong Kong</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05qghxh33</institution-id><institution>Department of Pathology and Laboratory Medicine, Stony Brook University, Long Island</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f54p054</institution-id><institution>Department of Epidemiology and Population Health, Stanford University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Stanford</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Malagón</surname><given-names>Talía</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap><country>Canada</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Franco</surname><given-names>Eduardo L</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap><country>Canada</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>04</day><month>04</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e85679</elocation-id><history><date date-type="received" iso-8601-date="2022-12-20"><day>20</day><month>12</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-03-20"><day>20</day><month>03</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-12-19"><day>19</day><month>12</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.12.18.22283642"/></event></pub-history><permissions><copyright-statement>© 2023, Muka et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Muka et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-85679-v2.pdf"/><abstract><p>The relocation and reconstruction of health care resources and systems during the coronavirus disease 2019 (COVID-19) pandemic may have affected cancer care. An umbrella review was undertaken to summarize the findings from systematic reviews on impact of the COVID-19 pandemic on cancer treatment modification, delays, and cancellations; delays or cancellations in screening and diagnosis; psychosocial well-being, financial distress, and use of telemedicine as well as on other aspects of cancer care. Bibliographic databases were searched for relevant systematic reviews with or without meta-analysis published before November 29th, 2022. Abstract, full- text screening, and data extraction were performed by two independent reviewers. AMSTAR-2 was used for critical appraisal of included systematic reviews. Fifty-one systematic reviews were included in our analysis. Most reviews were based on observational studies judged to be at medium and high risk of bias. Only two reviews had high or moderate scores based on AMSTAR-2. Findings suggest treatment modifications in cancer care during the pandemic versus the pre-pandemic period were based on low level of evidence. Different degrees of delays and cancellations in cancer treatment, screening, and diagnosis were observed, with low- and- middle- income countries and countries that implemented lockdowns being disproportionally affected. A shift from in-person appointments to telemedicine use was observed, but utility of telemedicine, challenges in implementation and cost-effectiveness in cancer care were little explored. Evidence was consistent in suggesting psychosocial well-being of patients with cancer deteriorated, and cancer patients experienced financial distress, albeit results were in general not compared to pre-pandemic levels. Impact of cancer care disruption during the pandemic on cancer prognosis was little explored. In conclusion, substantial but heterogenous impact of COVID-19 pandemic on cancer care has been observed.</p></abstract><abstract abstract-type="plain-language-summary"><title>eLife digest</title><p>The onset of the COVID-19 pandemic disrupted many aspects of human life, not least healthcare. As resources were redistributed towards the crisis, social isolation rules also limited access to medical professionals. In particular, these measures may have affected many aspects of cancer care, such as early detection or treatment.</p><p>Many studies have aimed to capture the impact of these changes, but most have been observational, with researchers recording events without trying to impose a controlled design. These investigations also often faced limitations such as small sample sizes, or only focusing on one aspect of cancer care. Systemic reviews, which synthetize and assess existing research on a topic, have helped to bypass these constraints. However, they are themselves not devoid of biases. Overall, a clear, unified picture of the impact of COVID-19 on cancer care is yet to emerge.</p><p>In response, Muka et al. carried an umbrella analysis of 51 systematic reviews on this topic. They used a well-known critical appraisal tool to assess the methodological rigor of each of these studies, while also summarising their findings. This work aimed to capture many aspects of the patients’ experience, from diagnosis to treatment and the financial, psychological, physical and social impact of the disease.</p><p>The results confirmed that the pandemic had a substantial impact on cancer care, including delays in screening, diagnosis and treatment. Throughout this period cancer patients experienced increased rates of depression, post-traumatic stress and fear of their cancer progressing. The long-term consequences of these disruptions remain to be uncovered.</p><p>However, Muka et al. also showed that, overall, these conclusions rely on low-quality studies which may have introduced unaccountable biases. In addition, their review highlights that most of the data currently available has been collected in high- and middle-income countries, with evidence lacking from regions of the world with more limited resources.</p><p>In the short-term, these results indicate that interventions may be needed to mitigate the negative impact of the pandemic on cancer care; in the long-term, they also demonstrate the importance of rigorous systematic reviews in guiding decision making. By shining a light on the ripple effects of certain decisions about healthcare resources, this work could also help to shape the response to future pandemics.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>cancer</kwd><kwd>prevention</kwd><kwd>COVID-19</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><funding-statement>No external funding was received for this work.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A diverse and substantial impact of the COVID-19 pandemic on cancer care is observed, including delays in treatment, screening, and diagnosis, as well as on the psychosocial welling of patients with cancer.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The coronavirus disease 2019 (COVID-19) pandemic and the mitigation measures that were undertaken posed major challenges to cancer care. The rapid spread of COVID-19 and early data showing patients with cancer were at increased risk of morbidity and mortality after Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, prompted changes in healthcare delivery (<xref ref-type="bibr" rid="bib60">Venkatesulu et al., 2020</xref>). These changes included reduction of medical activities, reallocation of healthcare workers, shifting in-person appointments to remote consultations, and limiting access of patients to care facilities (<xref ref-type="bibr" rid="bib12">Dhada et al., 2021</xref>).</p><p>Concerns have been raised that disruption of healthcare services might have had multidimensional impact in cancer care. Indeed, several studies have described delays and cancellation in treatment, screening, and diagnosis (<xref ref-type="bibr" rid="bib57">Teglia et al., 2022a</xref>; <xref ref-type="bibr" rid="bib58">Teglia et al., 2022b</xref>; <xref ref-type="bibr" rid="bib41">Nikolopoulos et al., 2022</xref>). For example, two meta-analyses showed that during the pandemic there was a ~50% reduction in breast and cervical cancer screening, and that there was 18.7% reduction for all cancer treatments, with surgical treatment showing the highest reduction (<xref ref-type="bibr" rid="bib57">Teglia et al., 2022a</xref>; <xref ref-type="bibr" rid="bib58">Teglia et al., 2022b</xref>). In addition, several studies have highlighted deterioration of psychological well-being of patients with cancer, and psychological, ethical, spiritual, and financial needs of patients with cancer were also affected (<xref ref-type="bibr" rid="bib65">Zhang et al., 2022</xref>; <xref ref-type="bibr" rid="bib26">Kirby et al., 2022</xref>). While several systematic reviews have examined the impact of COVID-19 on cancer care, they evaluated different outcomes and periods of the pandemic, and thus the available review findings are rather fragmented (<xref ref-type="bibr" rid="bib57">Teglia et al., 2022a</xref>; <xref ref-type="bibr" rid="bib58">Teglia et al., 2022b</xref>; <xref ref-type="bibr" rid="bib14">Donkor et al., 2021</xref>; <xref ref-type="bibr" rid="bib19">Gascon et al., 2022</xref>; <xref ref-type="bibr" rid="bib23">Hojaij et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Legge et al., 2022</xref>; <xref ref-type="bibr" rid="bib39">Murphy et al., 2022</xref>; <xref ref-type="bibr" rid="bib17">Gadsden et al., 2022</xref>; <xref ref-type="bibr" rid="bib30">Majeed et al., 2022</xref>). A comprehensive review of impact of COVID-19 on several aspects of cancer would be essential to understand gaps and scale-up evidence-based interventions, including learning lessons for future pandemics. In addition, although systematic reviews are important for public health and policy decision-making during the pandemic, the level of methodological rigor they implemented is unclear.</p><p>In the current study, we performed an umbrella review of systematic reviews to summarize the impact of COVID-19 on several aspects of cancer care, including treatment, diagnosis, financial, psychological, and social dimensions. We assessed the amount and geographical breadth of the available evidence and methodological rigor of the primary studies included in each review (as assessed by the reviewers) and of the systematic reviews themselves; and summarized the conclusions from different reviews on COVID-19 impact.</p></sec><sec id="s2" sec-type="results"><title>Results</title><p>Our search strategy identified 1172 citations. Based on title and abstract screening, we retrieved full texts of 96 articles for further screening. Of those, 45 articles did not meet our eligibility criteria, thus leaving 51 articles to be included in our final analysis. <xref ref-type="fig" rid="fig1">Figure 1</xref> summarizes our screening procedure. No additional study was found from screening of references of the included studies.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Flowchart of identification, screening, eligibility, inclusion, and exclusion of retrieved studies*.</title><p>*In the search, we did not include any language restriction filter. However, during full-text screening we included only studies that were in English. **WHO COVID-19 database does not allow to specify the search by both date and month, and the search for this specific database is up to end-December 2022. Any full text (<italic>n</italic> = 0) that was eligible and published after November 29, 2022, was excluded.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85679-fig1-v2.tif"/></fig><sec id="s2-1"><title>Characteristics of the included systematic reviews</title><p>Of the 51 included systematic reviews, 14 articles also included a quantitative analysis/meta-analysis with one being individual participant meta-analysis (<xref ref-type="bibr" rid="bib12">Dhada et al., 2021</xref> ; <xref ref-type="bibr" rid="bib57">Teglia et al., 2022a</xref>; <xref ref-type="bibr" rid="bib58">Teglia et al., 2022b</xref>; <xref ref-type="bibr" rid="bib41">Nikolopoulos et al., 2022</xref>; <xref ref-type="bibr" rid="bib65">Zhang et al., 2022</xref>; <xref ref-type="bibr" rid="bib26">Kirby et al., 2022</xref>; <xref ref-type="bibr" rid="bib14">Donkor et al., 2021</xref>; <xref ref-type="bibr" rid="bib19">Gascon et al., 2022</xref>; <xref ref-type="bibr" rid="bib23">Hojaij et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Legge et al., 2022</xref>; <xref ref-type="bibr" rid="bib39">Murphy et al., 2022</xref>; <xref ref-type="bibr" rid="bib17">Gadsden et al., 2022</xref>; <xref ref-type="bibr" rid="bib30">Majeed et al., 2022</xref>; <xref ref-type="bibr" rid="bib1">Adham et al., 2022</xref>; <xref ref-type="bibr" rid="bib3">Alom et al., 2021</xref>; <xref ref-type="bibr" rid="bib4">Ayubi et al., 2021</xref>; <xref ref-type="bibr" rid="bib18">Garg et al., 2020</xref>; <xref ref-type="bibr" rid="bib25">Jammu et al., 2021</xref>; <xref ref-type="bibr" rid="bib29">Lu et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Momenimovahed et al., 2021</xref>; <xref ref-type="bibr" rid="bib36">Mostafaei et al., 2022</xref>; <xref ref-type="bibr" rid="bib37">Moujaess et al., 2020</xref>; <xref ref-type="bibr" rid="bib38">Muls et al., 2022</xref>; <xref ref-type="bibr" rid="bib42">Pacheco et al., 2021</xref>; <xref ref-type="bibr" rid="bib47">Rohilla et al., 2021</xref>; <xref ref-type="bibr" rid="bib48">Salehi et al., 2022</xref>; <xref ref-type="bibr" rid="bib55">Sun et al., 2021</xref>; <xref ref-type="bibr" rid="bib64">Zapała et al., 2022</xref>; <xref ref-type="bibr" rid="bib2">Alkatout et al., 2021</xref>; <xref ref-type="bibr" rid="bib13">Di Cosimo et al., 2022</xref>; <xref ref-type="bibr" rid="bib15">Fancellu et al., 2022</xref>; <xref ref-type="bibr" rid="bib16">Ferrara et al., 2022</xref>; <xref ref-type="bibr" rid="bib22">Hesary and Salehiniya, 2022</xref>; <xref ref-type="bibr" rid="bib28">Lignou et al., 2022</xref>; <xref ref-type="bibr" rid="bib32">Mayo et al., 2021</xref>; <xref ref-type="bibr" rid="bib33">Mazidimoradi et al., 2021</xref>; <xref ref-type="bibr" rid="bib34">Mazidimoradi et al., 2022</xref>; <xref ref-type="bibr" rid="bib40">Ng and Hamilton, 2022</xref>; <xref ref-type="bibr" rid="bib43">Pararas et al., 2022</xref>; <xref ref-type="bibr" rid="bib46">Riera et al., 2021</xref>; <xref ref-type="bibr" rid="bib49">Sarich et al., 2022</xref>; <xref ref-type="bibr" rid="bib50">Sasidharanpillai and Ravishankar, 2022</xref>; <xref ref-type="bibr" rid="bib56">Tang et al., 2022</xref>; <xref ref-type="bibr" rid="bib59">Thomson et al., 2020</xref>; <xref ref-type="bibr" rid="bib61">Vigliar et al., 2020</xref>; <xref ref-type="bibr" rid="bib11">de Bock et al., 2022</xref>). Other key characteristics of the 51 systematic reviews are shown in <xref ref-type="table" rid="table1">Table 1</xref> (more extensive details appear in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref> and <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). The median number of bibliographic databases/data sources that were searched was 3; the most searched databases were PubMed (<italic>n</italic> = 35), Medline (<italic>n</italic> = 25), Embase (<italic>n</italic> = 22), Scopus (<italic>n</italic> = 19), Web of Science (<italic>n</italic> = 13), and The Cumulative Index to Nursing and Allied Health Literature – CINAHL database (<italic>n</italic> = 10). One review searched for mobile applications using the iOS App Store and Android Google Play (<xref ref-type="bibr" rid="bib29">Lu et al., 2021</xref>). The median number of studies included in the systematic reviews was 31 (interquartile range, 15; 51). The type of study designs included across reviews varied, but most reviews included data from observational study designs of cross-sectional and retrospective nature. Twenty-one reviews focused/reported exclusively on studies that include pre-pandemic controls. Twenty reviews provided data only on site-specific cancers, while the rest for any cancer site with or without data on site-specific cancers. Nineteen reviews assessed only one aspect of cancer care, while the rest examined two or more of our pre-defined outcomes. The date of last search varied from April 2020 to May 2022, with 16 reviews ending searches during 2020, 25 during 2021, and 5 during 2022; 4 reviews did not provide information on date of last search.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Characteristics of included systematic reviews.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Author, year of publication</th><th align="left" valign="bottom">Meta-analysis</th><th align="left" valign="bottom">Number of included studies</th><th align="left" valign="bottom">Countries<xref ref-type="table-fn" rid="table1fn1">*</xref></th><th align="left" valign="bottom">Pre-pandemic controls</th><th align="left" valign="bottom">Cancer types</th><th align="left" valign="bottom">Aspects assessed</th><th align="left" valign="bottom">Last search</th></tr></thead><tbody><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib1">Adham et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">Globally</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">H&amp;N</td><td align="left" valign="bottom">MT, O</td><td align="char" char="hyphen" valign="bottom">15-Jul-20</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib2">Alkatout et al., 2021</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">16</td><td align="left" valign="bottom">Multiple countries, including<break/>US, TW, BE, NL, JP, IT, UK, AS, CA</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">DCS, RD</td><td align="char" char="hyphen" valign="bottom">28-Dec-20</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib3">Alom et al., 2021</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">72</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">All</td><td align="left" valign="bottom">MT, TL, O</td><td align="char" char="hyphen" valign="bottom">1-Sep-20</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib4">Ayubi et al., 2021</xref></td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">34</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">All</td><td align="left" valign="bottom">PSND, O</td><td align="char" char="hyphen" valign="bottom">3-Jan-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib5">Azab and Azzam, 2021</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">51</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">Glioma</td><td align="left" valign="bottom">MT</td><td align="left" valign="bottom">End of 2020</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib7">Bezerra et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">8</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">TL</td><td align="char" char="hyphen" valign="bottom">01-Apr-2021</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib9">Crosby and Sharma, 2020</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">45</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">No/NS</td><td align="left" valign="bottom">H&amp;N</td><td align="left" valign="bottom">MT</td><td align="char" char="hyphen" valign="bottom">08-Apr-2020</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib11">de Bock et al., 2022</xref></td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">24</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">ALL, BC</td><td align="left" valign="bottom">Delayed and/or canceled treatment<break/>Other aspects</td><td align="char" char="hyphen" valign="bottom">21-Mar-2021</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib12">Dhada et al., 2021</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">19</td><td align="left" valign="bottom">Multiple countries, including IT, US, UK, NL</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">DCT, DCS, PSND, TL, FBD, SIA</td><td align="char" char="hyphen" valign="bottom">1-Dec-20</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib13">Di Cosimo et al., 2022</xref></td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">56</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">MT, DCT, TL, O</td><td align="char" char="hyphen" valign="bottom">11-Dec-20</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Donkor et al., 2021</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">11</td><td align="left" valign="bottom">Multiple countries, including CN, IR, BR, ZA</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">O</td><td align="char" char="hyphen" valign="bottom">3-Aug-20</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Fancellu et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">7</td><td align="left" valign="bottom">IT</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">CRC</td><td align="left" valign="bottom">DCS, RD</td><td align="char" char="hyphen" valign="bottom">31-Jan-22</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib16">Ferrara et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">33</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">CV</td><td align="left" valign="bottom">DCT, DCS, RD, RHPV</td><td align="char" char="hyphen" valign="bottom">8-Feb-22</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib17">Gadsden et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">17</td><td align="left" valign="bottom">Multiple countries, including IN, SL, BA</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">DCT, O</td><td align="char" char="hyphen" valign="bottom">15-Dec-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib18">Garg et al., 2020</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">212</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">MT</td><td align="char" char="hyphen" valign="bottom">2-May-20</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib19">Gascon et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">23</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">H&amp;N</td><td align="left" valign="bottom">MT, O</td><td align="char" char="hyphen" valign="bottom">1-May-20</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib22">Hesary and Salehiniya, 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">22</td><td align="left" valign="bottom">Multiple countries, including<break/>IT, UK, PG, NL, CN, IN, JP, TU, IR, SN</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">GA</td><td align="left" valign="bottom">MT, DCS, RD, PSND</td><td align="char" char="hyphen" valign="bottom">31-Dec-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib23">Hojaij et al., 2020</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">35</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">H&amp;N, OTO</td><td align="left" valign="bottom">MT, TL, O</td><td align="char" char="hyphen" valign="bottom">31-Dec-20</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib25">Jammu et al., 2021</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">19</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">DCT, PSND, FBD</td><td align="char" char="hyphen" valign="bottom">27-Aug-20</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Kirby et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">56</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">PSND, FBD, SIA</td><td align="char" char="hyphen" valign="bottom">31-Mar-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib27">Legge et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">18</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">PSND, FBD, SIA</td><td align="char" char="hyphen" valign="bottom">25-May-22</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Lignou et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">32</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">PC</td><td align="left" valign="bottom">DCT, RD, TL</td><td align="char" char="hyphen" valign="bottom">1-Aug-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib29">Lu et al., 2021</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">41<xref ref-type="table-fn" rid="table1fn2"><sup>†</sup></xref></td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">TL</td><td align="char" char="hyphen" valign="bottom">1-May-20</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib30">Majeed et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">60</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">Yes, but NS</td><td align="left" valign="bottom">PC</td><td align="left" valign="bottom">DCT, RD, TL</td><td align="char" char="hyphen" valign="bottom">3-Nov-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib32">Mayo et al., 2021</xref></td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">13</td><td align="left" valign="bottom">Multiple countries, including<break/>IT, AU, TW, US, FR, NL</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">DCT, DCS</td><td align="char" char="hyphen" valign="bottom">10-Feb-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Mazidimoradi et al., 2021</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">43</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">CRC</td><td align="left" valign="bottom">MT, DCT, RD</td><td align="char" char="hyphen" valign="bottom">1-Jun-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib34">Mazidimoradi et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">25</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">CRC</td><td align="left" valign="bottom">DCS</td><td align="char" char="hyphen" valign="bottom">1-Jun-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib35">Momenimovahed et al., 2021</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">55</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">PSND</td><td align="char" char="hyphen" valign="bottom">30-Jun-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Mostafaei et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">22</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">TL</td><td align="char" char="hyphen" valign="bottom">1-Jun-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib37">Moujaess et al., 2020</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">88</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">DCT, O</td><td align="char" char="hyphen" valign="bottom">15-Apr-20</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib38">Muls et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">51</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">PSND</td><td align="char" char="hyphen" valign="bottom">1-Oct-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Murphy et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">37</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">TL</td><td align="char" char="hyphen" valign="bottom">31-Mar-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">Ng and Hamilton, 2022</xref></td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">31</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">BC</td><td align="left" valign="bottom">DCS, RD</td><td align="char" char="hyphen" valign="bottom">1-Oct-20</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib41">Nikolopoulos et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">15</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">Yes, but NS</td><td align="left" valign="bottom">GC</td><td align="left" valign="bottom">MT, DCT, RD, PSND</td><td align="char" char="hyphen" valign="bottom">10-Feb-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib42">Pacheco et al., 2021</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">9</td><td align="left" valign="bottom">Multiple countries, including<break/>US, IT, CN, SP, UK, IR</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">DCT, O</td><td align="left" valign="bottom">NP</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib43">Pararas et al., 2022</xref></td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">10</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">CRC</td><td align="left" valign="bottom">O</td><td align="left" valign="bottom">NP</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib44">Pascual et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">12</td><td align="left" valign="bottom">Multiple countries from low- and middle-income countries</td><td align="left" valign="bottom">Yes, but NS</td><td align="left" valign="bottom">Surgical Neuro-Oncology</td><td align="left" valign="bottom">MD, RD, TL, O</td><td align="char" char="hyphen" valign="bottom">01-Sep- 2021</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib45">Piras et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">281</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">MT, DCT, SIA, PSND</td><td align="char" char="hyphen" valign="bottom">31-Dec-2021</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib46">Riera et al., 2021</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">62</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">DCT</td><td align="left" valign="bottom">NP</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib47">Rohilla et al., 2021</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">IN</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">PSND, O</td><td align="char" char="hyphen" valign="bottom">3-Feb-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib48">Salehi et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">16</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">TL</td><td align="char" char="hyphen" valign="bottom">1-Apr-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib49">Sarich et al., 2022</xref></td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">44</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">NA</td><td align="left" valign="bottom">RF</td><td align="char" char="hyphen" valign="bottom">5-Nov-20</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib50">Sasidharanpillai and Ravishankar, 2022</xref></td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">7</td><td align="left" valign="bottom">Multiple countries, including<break/>SL, IT, CA, SC, BE, US</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">CV</td><td align="left" valign="bottom">DCT, RD</td><td align="char" char="hyphen" valign="bottom">1-Sep-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib55">Sun et al., 2021</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">IT, AM, UK</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">BC</td><td align="left" valign="bottom">MT</td><td align="char" char="hyphen" valign="bottom">1-Feb-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib56">Tang et al., 2022</xref></td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">14</td><td align="left" valign="bottom">TU, CN, UK, IT, DN, AS, AU</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">CRC</td><td align="left" valign="bottom">O</td><td align="char" char="hyphen" valign="bottom">12-Jan-22</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib57">Teglia et al., 2022a</xref></td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">39</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">BC, CRC, CV</td><td align="left" valign="bottom">DCT, RD</td><td align="char" char="hyphen" valign="bottom">12-Dec-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib58">Teglia et al., 2022b</xref></td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">47</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">DCT</td><td align="char" char="hyphen" valign="bottom">12-Dec-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib59">Thomson et al., 2020</xref></td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">54</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">O</td><td align="char" char="hyphen" valign="bottom">1-Jun-21</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib61">Vigliar et al., 2020</xref></td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">41<xref ref-type="table-fn" rid="table1fn3"><sup>‡</sup></xref></td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">Yes</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">DCS, RD</td><td align="char" char="hyphen" valign="bottom">30-Apr-20</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib64">Zapała et al., 2022</xref></td><td align="left" valign="bottom">No</td><td align="char" char="." valign="bottom">160</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">DCT, PSND, TL</td><td align="left" valign="bottom">NP</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib65">Zhang et al., 2022</xref></td><td align="left" valign="bottom">Yes</td><td align="char" char="." valign="bottom">40</td><td align="left" valign="bottom">Multiple countries</td><td align="left" valign="bottom">No</td><td align="left" valign="bottom">ALL</td><td align="left" valign="bottom">PSND</td><td align="char" char="hyphen" valign="bottom">31-Jan-22</td></tr></tbody></table><table-wrap-foot><fn id="table1fn1"><label>*</label><p>Multiple countries refer to inclusion of studies for final analysis that used data from more than one country. If complete information on location from all primary studies were provided, then specific countries were listed.</p></fn><fn id="table1fn2"><label>†</label><p>Apps.</p></fn><fn id="table1fn3"><label>‡</label><p>Respondents.</p></fn><fn><p>AM, America; BC; AS, Austria; AU, Australia; BA, Bangladesh; BC, breast cancer; BE, Belgium; BR, Brazil; CA, Canada; China; CRC, colorectal cancer; CV, cervical cancer; DN, Denmark; FR, France; GA, gastric cancer; GC, gynecological cancer; H&amp;N, head and neck cancer; IN, India; IR, Iran; IT, Italy; JP, Japan; NA, not applicable; NL, Netherlands; NP, not provided; OTO, otorhinolaryngology cancer; PC, pediatric cancer; PG, Portugal; SC, Scotland; SL, Slovenia or Sri Lanka; SN, Singapore; SP, Spain; TU, Turkey; TW, Taiwan; UK, United Kingdom; United States; ZA, Zambia;MT, modification of treatment; DCT, delayed and/or canceled treatment; DCS, delayed and canceled screening; RD, reduced diagnosis: RHPV, reduced uptake of HPV vaccination; TL, telemedicine; PSND, psychological needs/distress; FBD, financial burden/distress; SIA, social isolation; O, other aspects.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-2"><title>Geographical distribution</title><p>Out of 51 reviews, 46 provided some information on geographical distribution of the included primary studies. Of those, most reviews provided data from different countries, while only two studies (3.9%) focused on data from India (<xref ref-type="bibr" rid="bib47">Rohilla et al., 2021</xref>) and Italy (<xref ref-type="bibr" rid="bib15">Fancellu et al., 2022</xref>) exclusively. Also the majority of the evidence was derived from high- and middle-income countries.</p></sec><sec id="s2-3"><title>Risk of bias of primary studies included in the systematic reviews and GRADE assessments</title><p>Of the 51 reviews, 32 assessed risk of bias of the included studies (<xref ref-type="table" rid="table2">Table 2</xref> and details in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>). Thirteen different risks of bias checklists were used, and the most common checklists used to assess methodological rigor were Newcastle-Ottawa Scale (NOS) (<italic>n</italic> = 10) and Joanna Briggs Institute tools (<italic>n</italic> = 7). Of the systematic reviews that assess methodological rigor of the individual studies, 8 concluded strong evidence, 19 mixed evidence, 3 weak evidence, and 2 did not provide any results. Excluding the NOS assessments [since NOS has been criticized to not provide accurate assessment of methodological rigor (<xref ref-type="bibr" rid="bib54">Stang, 2010</xref>)], the respective numbers were 3, 14, 3, and 2. Only two reviews used GRADE (Grading of Recommendations, Assessment, Development and Evaluations), concluding low to moderate certainty in the results.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Methodological rigor of included reviews.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Author</th><th align="left" valign="bottom">Checklist use</th><th align="left" valign="bottom">Methodological rigor conclusion category</th><th align="left" valign="bottom">GRADE</th></tr></thead><tbody><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib1">Adham et al., 2022</xref></td><td align="left" valign="bottom">CEBM</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib2">Alkatout et al., 2021</xref></td><td align="left" valign="bottom">NOS</td><td align="left" valign="bottom">Strong evidence</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib3">Alom et al., 2021</xref></td><td align="left" valign="bottom">NHLBI, NIH</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib4">Ayubi et al., 2021</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib5">Azab and Azzam, 2021</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib7">Bezerra et al., 2022</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib13">Di Cosimo et al., 2022</xref></td><td align="left" valign="bottom">CLARITY</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib9">Crosby and Sharma, 2020</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib11">de Bock et al., 2022</xref></td><td align="left" valign="bottom">ROBINS-I</td><td align="left" valign="bottom">Strong evidence</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib12">Dhada et al., 2021</xref></td><td align="left" valign="bottom">CASP, NHLBI, NIH</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Donkor et al., 2021</xref></td><td align="left" valign="bottom">JBI</td><td align="left" valign="bottom">Weak</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Fancellu et al., 2022</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib16">Ferrara et al., 2022</xref></td><td align="left" valign="bottom">NOS</td><td align="left" valign="bottom">Strong evidence</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib17">Gadsden et al., 2022</xref></td><td align="left" valign="bottom">JBI, ROBINS-I</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib18">Garg et al., 2020</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib19">Gascon et al., 2022</xref></td><td align="left" valign="bottom">Agree II</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib22">Hesary and Salehiniya, 2022</xref></td><td align="left" valign="bottom">NOS</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib23">Hojaij et al., 2020</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib25">Jammu et al., 2021</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Kirby et al., 2022</xref></td><td align="left" valign="bottom">JBI, CHEC</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib27">Legge et al., 2022</xref></td><td align="left" valign="bottom">MMAT</td><td align="left" valign="bottom">Strong evidence</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Lignou et al., 2022</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib29">Lu et al., 2021</xref></td><td align="left" valign="bottom">MARS</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib30">Majeed et al., 2022</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Low to moderate certainty</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib32">Mayo et al., 2021</xref></td><td align="left" valign="bottom">NOS</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Moderate to high</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Mazidimoradi et al., 2021</xref></td><td align="left" valign="bottom">NOS</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib34">Mazidimoradi et al., 2022</xref></td><td align="left" valign="bottom">NOS</td><td align="left" valign="bottom">Strong evidence</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib35">Momenimovahed et al., 2021</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Mostafaei et al., 2022</xref></td><td align="left" valign="bottom">JBI</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib37">Moujaess et al., 2020</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib38">Muls et al., 2022</xref></td><td align="left" valign="bottom">MMAT</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Murphy et al., 2022</xref></td><td align="left" valign="bottom">JBI, CHEC</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">Ng and Hamilton, 2022</xref></td><td align="left" valign="bottom">NOS</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib41">Nikolopoulos et al., 2022</xref></td><td align="left" valign="bottom">NOS</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib42">Pacheco et al., 2021</xref></td><td align="left" valign="bottom">JBI, ROBINS-I</td><td align="left" valign="bottom">Weak</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib43">Pararas et al., 2022</xref></td><td align="left" valign="bottom">NOS</td><td align="left" valign="bottom">Strong evidence</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib44">Pascual et al., 2022</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib45">Piras et al., 2022</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib46">Riera et al., 2021</xref></td><td align="left" valign="bottom">ROBINS-I</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib47">Rohilla et al., 2021</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib48">Salehi et al., 2022</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib49">Sarich et al., 2022</xref></td><td align="left" valign="bottom">ROBINS-I</td><td align="left" valign="bottom">Weak evidence</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib50">Sasidharanpillai and Ravishankar, 2022</xref></td><td align="left" valign="bottom">NHLBI, NIH</td><td align="left" valign="bottom">Strong evidence</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib55">Sun et al., 2021</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib56">Tang et al., 2022</xref></td><td align="left" valign="bottom">NOS</td><td align="left" valign="bottom">Strong evidence</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib57">Teglia et al., 2022a</xref></td><td align="left" valign="bottom">CASP</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib58">Teglia et al., 2022b</xref></td><td align="left" valign="bottom">CASP</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib59">Thomson et al., 2020</xref></td><td align="left" valign="bottom">ASTRO</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib61">Vigliar et al., 2020</xref></td><td align="left" valign="bottom">Not applicable</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib64">Zapała et al., 2022</xref></td><td align="left" valign="bottom">Not applied</td><td align="left" valign="bottom">Not provided</td><td align="left" valign="bottom">Not provided</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib65">Zhang et al., 2022</xref></td><td align="left" valign="bottom">JBI</td><td align="left" valign="bottom">Mixed/Intermediate</td><td align="left" valign="bottom">Not provided</td></tr></tbody></table><table-wrap-foot><fn><p>CEBM, Critical appraisal tool of qualitative studies from Centre of Evidence-based Medicine (CEBM), University of Oxford; ASTRO, The American Society of Radiation Oncology; CASP, <ext-link ext-link-type="uri" xlink:href="https://casp-uk.net/casp-tools-checklists/">https://casp-uk.net/casp-tools-checklists/</ext-link>; CHEC, Consensus on Health Economic Criteria: CLARITY, ‘Risk of bias instrument for cross-sectional surveys of attitudes and practices’ from the CLARITY Group at McMaster University; JBI, Joanna Briggs Institute; MARS, Mobile Apps Rating Scale; MMAT, Mixed Methods Appraisal Tool; NHLBI, NHI, National Institute of Health Checklist; NOS, Newcastle-Ottawa Quality Assessment: RBC, Risk of Bias Checklist for Prevalence Studies by <xref ref-type="bibr" rid="bib24">Hoy et al., 2012</xref>.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-4"><title>Methodological rigor of included systematic reviews</title><p><xref ref-type="table" rid="table3">Table 3</xref> shows the AMSTAR-2 evaluations for the included systematic reviews. Only two reviews scored moderate to high quality, while the rest were evaluated as low or critically low quality due to not meeting one or more of the seven domains considered critical. Most of the studies did not provide the list of excluded studies during the full-text screening, and did not account for methodological rigor of included studies when interpreting/discussing the results of the reviews.</p><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>Methodological assessment of the included reviews – AMSTAR-2 evaluation (16 questions)<xref ref-type="table-fn" rid="table3fn18">*</xref>.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Authors, year of publication</th><th align="left" valign="bottom">Q1</th><th align="left" valign="bottom">Q2</th><th align="left" valign="bottom">Q3</th><th align="left" valign="bottom">Q4</th><th align="left" valign="bottom">Q5</th><th align="left" valign="bottom">Q6</th><th align="left" valign="bottom">Q7</th><th align="left" valign="bottom">Q8</th><th align="left" valign="bottom">Q9<xref ref-type="table-fn" rid="table3fn19"><sup>†</sup></xref></th><th align="left" valign="bottom">Q10</th><th align="left" valign="bottom">Q11</th><th align="left" valign="bottom">Q12</th><th align="left" valign="bottom">Q13</th><th align="left" valign="bottom">Q14</th><th align="left" valign="bottom">Q15</th><th align="left" valign="bottom">Q16</th><th align="left" valign="bottom">Overall assessment</th></tr></thead><tbody><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib1">Adham et al., 2022</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib2">Alkatout et al., 2021</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib3">Alom et al., 2021</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib4">Ayubi et al., 2021</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib5">Azab and Azzam, 2021</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib7">Bezerra et al., 2022</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib9">Crosby and Sharma, 2020</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib11">de Bock et al., 2022</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib12">Dhada et al., 2021</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib13">Di Cosimo et al., 2022</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib14">Donkor et al., 2021</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib15">Fancellu et al., 2022</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib16">Ferrara et al., 2022</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib17">Gadsden et al., 2022</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib18">Garg et al., 2020</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib19">Gascon et al., 2022</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib22">Hesary and Salehiniya, 2022</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib23">Hojaij et al., 2020</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib25">Jammu et al., 2021</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Kirby et al., 2022</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib27">Legge et al., 2022</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Lignou et al., 2022</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib29">Lu et al., 2021</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib30">Majeed et al., 2022</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib32">Mayo et al., 2021</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib34">Mazidimoradi et al., 2022</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib33">Mazidimoradi et al., 2021</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib35">Momenimovahed et al., 2021</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib36">Mostafaei et al., 2022</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib38">Muls et al., 2022</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Murphy et al., 2022</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">Ng and Hamilton, 2022</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib41">Nikolopoulos et al., 2022</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib42">Pacheco et al., 2021</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">High quality</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib43">Pararas et al., 2022</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib44">Pascual et al., 2022</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib45">Piras et al., 2022</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib46">Riera et al., 2021</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Moderate quality</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib47">Rohilla et al., 2021</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib48">Salehi et al., 2022</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib49">Sarich et al., 2022</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib50">Sasidharanpillai and Ravishankar, 2022</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib55">Sun et al., 2021</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib56">Tang et al., 2022</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib57">Teglia et al., 2022a</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib58">Teglia et al., 2022b</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib59">Thomson et al., 2020</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib61">Vigliar et al., 2020</xref><xref ref-type="table-fn" rid="table3fn19"><sup>†</sup></xref></td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">NA</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib64">Zapała et al., 2022</xref></td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">na</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Critical low</td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib65">Zhang et al., 2022</xref></td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">py</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">n</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">y</td><td align="left" valign="bottom">Low</td></tr></tbody></table><table-wrap-foot><fn><p>AMSTAR-2 overall assessment rating: high—the review provides an accurate and comprehensive summary of the results of the available studies that addresses the question of interest; moderate—the review has more than one weakness, but no critical flaws. It may provide an accurate summary of the results of the available studies; low—the review has a critical flaw and may not provide an accurate and comprehensive summary of the available studies that address the question of interest; or critically low—the review has more than one critical flaw and should not be relied on to provide an accurate and comprehensive summary of the available studies.</p></fn><fn><p>Q1: Did the research questions and inclusion criteria for the review include the components of PICO?</p></fn><fn><p>Q2: Did the report of the review contain an explicit statement that the review methods were established prior to the conduct of the review and did the report justify any significant deviations from the protocol?</p></fn><fn><p>Q3: Did the review authors explain their selection of the study designs for inclusion in the review?</p></fn><fn><p>Q4: Did the review authors use a comprehensive literature search strategy?</p></fn><fn><p>Q5: Did the review authors perform study selection in duplicate?</p></fn><fn><p>Q6: Did the review authors perform data extraction in duplicate?</p></fn><fn><p>Q7: Did the review authors provide a list of excluded studies and justify the exclusions?</p></fn><fn><p>Q8: Did the review authors describe the included studies in adequate detail?</p></fn><fn><p>Q9: Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review?</p></fn><fn><p>Q10: Did the review authors report on the sources of funding for the studies included in the review?</p></fn><fn><p>Q11: If meta-analysis was performed did the review authors use appropriate methods for statistical combination of results?</p></fn><fn><p>Q12: If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis?</p></fn><fn><p>Q13: Did the review authors account for RoB in individual studies when interpreting/discussing the results of the review?</p></fn><fn><p>Q14: Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review?</p></fn><fn><p>Q15: If they performed quantitative synthesis did the review authors carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of the review?</p></fn><fn><p>Q16: Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review?</p></fn><fn id="table3fn18"><label>*</label><p>The review scored yes if study used a checklist to evaluate methodological rigor, and partial yes if only GRADE assessment was provided without applying a checklist for assessing methodological rigor.</p></fn><fn id="table3fn19"><label>†</label><p>Individual participant meta-analysis and thus not applicable the AMSTAR evaluation.</p></fn><fn><p>n, no; na, not applicable; py, partially yes; y, yes.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-5"><title>Results and conclusions of systematic reviews and of meta-analyses</title><p>The main results and conclusions of the eligible systematic reviews are presented in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c-j</xref> for various aspects of cancer care. <xref ref-type="table" rid="table4">Table 4</xref> lists the effect sizes and confidence intervals (CIs) for the systematic reviews that used formal meta-analysis as well as heterogeneity metrics. <xref ref-type="fig" rid="fig2">Figure 2</xref> provides a summary of main findings of this umbrella review. Here, we present some key findings for each type of outcome:</p><sec id="s2-5-1"><title>Modification of treatment</title><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Visual summary.</title><p>CI, confidence interval.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85679-fig2-v2.tif"/></fig><table-wrap id="table4" position="float"><label>Table 4.</label><caption><title>Summary estimates of the meta-analysis included.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Author</th><th align="left" valign="bottom">No. of studies</th><th align="left" valign="bottom">Outcome</th><th align="left" valign="bottom">Estimate</th><th align="left" valign="bottom">LCI</th><th align="left" valign="bottom">UCI</th><th align="left" valign="bottom"><italic>I</italic><sup>2</sup></th><th align="left" valign="bottom">p-heterogeniety</th><th align="left" valign="bottom">Metric</th></tr></thead><tbody><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib4">Ayubi et al., 2021</xref></td><td align="char" char="." valign="bottom">15</td><td align="left" valign="bottom">Depression</td><td align="char" char="." valign="bottom">0.37</td><td align="char" char="." valign="bottom">0.27</td><td align="char" char="." valign="bottom">0.47</td><td align="char" char="." valign="bottom">99</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">Prev<xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">17</td><td align="left" valign="bottom">Anxiety</td><td align="char" char="." valign="bottom">0.38</td><td align="char" char="." valign="bottom">0.31</td><td align="char" char="." valign="bottom">0.46</td><td align="char" char="." valign="bottom">99</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">Prev<xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Anxiety</td><td align="char" char="." valign="bottom">0.25</td><td align="char" char="." valign="bottom">0.08</td><td align="char" char="." valign="bottom">0.42</td><td align="char" char="." valign="bottom">68</td><td align="char" char="." valign="bottom">0.02</td><td align="left" valign="bottom">SMD<xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib65">Zhang et al., 2022</xref></td><td align="char" char="." valign="bottom">28</td><td align="left" valign="bottom">Depression</td><td align="char" char="." valign="bottom">0.325</td><td align="char" char="." valign="bottom">0.263</td><td align="char" char="." valign="bottom">0.392</td><td align="char" char="." valign="bottom">99</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">Prev<xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">34</td><td align="left" valign="bottom">Anxiety</td><td align="char" char="." valign="bottom">0.313</td><td align="char" char="." valign="bottom">0.254</td><td align="char" char="." valign="bottom">0.375</td><td align="char" char="." valign="bottom">99</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">Prev<xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">8</td><td align="left" valign="bottom">PTSD</td><td align="char" char="." valign="bottom">0.288</td><td align="char" char="." valign="bottom">0.207</td><td align="char" char="." valign="bottom">0.368</td><td align="char" char="." valign="bottom">99</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">Prev<xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">Distress</td><td align="char" char="." valign="bottom">0.539</td><td align="char" char="." valign="bottom">0.469</td><td align="char" char="." valign="bottom">0.609</td><td align="char" char="." valign="bottom">67</td><td align="char" char="." valign="bottom">0.016</td><td align="left" valign="bottom">Prev<xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">Insomia</td><td align="char" char="." valign="bottom">0.232</td><td align="char" char="." valign="bottom">0.171</td><td align="char" char="." valign="bottom">0.293</td><td align="char" char="." valign="bottom">91</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">Prev<xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Fear of cancer progression</td><td align="char" char="." valign="bottom">0.674</td><td align="char" char="." valign="bottom">0.437</td><td align="char" char="." valign="bottom">0.91</td><td align="char" char="." valign="bottom">93</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">Prev<xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib13">Di Cosimo et al., 2022</xref></td><td align="char" char="." valign="bottom">28</td><td align="left" valign="bottom">Cancellation/delay of treatment</td><td align="char" char="." valign="bottom">0.58</td><td align="char" char="." valign="bottom">0.48</td><td align="char" char="." valign="bottom">0.67</td><td align="char" char="." valign="bottom">98</td><td align="char" char="." valign="bottom">&lt;0.01</td><td align="left" valign="bottom">Prop<xref ref-type="table-fn" rid="table4fn1">*</xref><xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">14</td><td align="left" valign="bottom">Modification of treatment</td><td align="char" char="." valign="bottom">0.65</td><td align="char" char="." valign="bottom">0.53</td><td align="char" char="." valign="bottom">0.75</td><td align="char" char="." valign="bottom">98</td><td align="char" char="." valign="bottom">&lt;0.01</td><td align="left" valign="bottom">Prop<xref ref-type="table-fn" rid="table4fn1">*</xref><xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">10</td><td align="left" valign="bottom">Delay of clinic visits</td><td align="char" char="." valign="bottom">0.75</td><td align="char" char="." valign="bottom">0.49</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">99</td><td align="char" char="." valign="bottom">&lt;0.01</td><td align="left" valign="bottom">Prop<xref ref-type="table-fn" rid="table4fn1">*</xref><xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">14</td><td align="left" valign="bottom">Reduction in activity</td><td align="char" char="." valign="bottom">0.58</td><td align="char" char="." valign="bottom">0.47</td><td align="char" char="." valign="bottom">0.68</td><td align="char" char="." valign="bottom">93</td><td align="char" char="." valign="bottom">&lt;0.01</td><td align="left" valign="bottom">Prop<xref ref-type="table-fn" rid="table4fn1">*</xref><xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">25</td><td align="left" valign="bottom">Use of remote consultation</td><td align="char" char="." valign="bottom">0.72</td><td align="char" char="." valign="bottom">0.59</td><td align="char" char="." valign="bottom">0.84</td><td align="char" char="." valign="bottom">99</td><td align="char" char="." valign="bottom">&lt;0.01</td><td align="left" valign="bottom">Prop<xref ref-type="table-fn" rid="table4fn1">*</xref><xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">7</td><td align="left" valign="bottom">Routine use of PPE (patients)</td><td align="char" char="." valign="bottom">0.81</td><td align="char" char="." valign="bottom">0.75</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">96</td><td align="char" char="." valign="bottom">&lt;0.01</td><td align="left" valign="bottom">Prop<xref ref-type="table-fn" rid="table4fn1">*</xref><xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">16</td><td align="left" valign="bottom">Routine use of PPE (workers)</td><td align="char" char="." valign="bottom">0.8</td><td align="char" char="." valign="bottom">0.61</td><td align="char" char="." valign="bottom">0.94</td><td align="char" char="." valign="bottom">99</td><td align="char" char="." valign="bottom">&lt;0.01</td><td align="left" valign="bottom">Prop<xref ref-type="table-fn" rid="table4fn1">*</xref><xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">18</td><td align="left" valign="bottom">Routine screening SARA-CoV-2 swab</td><td align="char" char="." valign="bottom">0.41</td><td align="char" char="." valign="bottom">0.3</td><td align="char" char="." valign="bottom">0.53</td><td align="char" char="." valign="bottom">96</td><td align="char" char="." valign="bottom">&lt;0.01</td><td align="left" valign="bottom">Prop<xref ref-type="table-fn" rid="table4fn1">*</xref><xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom" rowspan="3"><xref ref-type="bibr" rid="bib11">de Bock et al., 2022</xref></td><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">≥T2 stage during the COVID-19 pandemic compared to the pre-pandemic control group</td><td align="char" char="." valign="bottom">1.00</td><td align="char" char="." valign="bottom">0.72</td><td align="char" char="." valign="bottom">1.38</td><td align="char" char="." valign="bottom">58</td><td align="char" char="." valign="bottom">0.05</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">≥T3 stage during the COVID-19 pandemic compared to the pre-pandemic control group</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">0.69</td><td align="char" char="." valign="bottom">1.32</td><td align="char" char="." valign="bottom">39</td><td align="char" char="." valign="bottom">0.18</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">≥N1 stage during the COVID-19 pandemic compared to the pre-pandemic control group</td><td align="char" char="." valign="bottom">1.55</td><td align="char" char="." valign="bottom">0.87</td><td align="char" char="." valign="bottom">2.74</td><td align="char" char="." valign="bottom">3</td><td align="char" char="." valign="bottom">0.39</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib32">Mayo et al., 2021</xref></td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">Screening breast cancer</td><td align="char" char="." valign="bottom">0.63</td><td align="char" char="." valign="bottom">0.53</td><td align="char" char="." valign="bottom">0.77</td><td align="char" char="." valign="bottom">100</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">IRR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">Screening conlonc cancer</td><td align="char" char="." valign="bottom">0.11</td><td align="char" char="." valign="bottom">0.05</td><td align="char" char="." valign="bottom">0.24</td><td align="char" char="." valign="bottom">100</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">IRR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Screening cervical cancer</td><td align="char" char="." valign="bottom">0.1</td><td align="char" char="." valign="bottom">0.04</td><td align="char" char="." valign="bottom">0.24</td><td align="char" char="." valign="bottom">100</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">IRR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib40">Ng and Hamilton, 2022</xref></td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Screening breast cancer registry-based study</td><td align="char" char="." valign="bottom">0.59</td><td align="char" char="." valign="bottom">0.46</td><td align="char" char="." valign="bottom">0.7</td><td align="char" char="." valign="bottom">100</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">RR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">10</td><td align="left" valign="bottom">Screening breast cancer non-registry-based study</td><td align="char" char="." valign="bottom">0.47</td><td align="char" char="." valign="bottom">0.38</td><td align="char" char="." valign="bottom">0.58</td><td align="char" char="." valign="bottom">100</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">RR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Diagnosis breast cancer registry-based study</td><td align="char" char="." valign="bottom">0.82</td><td align="char" char="." valign="bottom">0.63</td><td align="char" char="." valign="bottom">1.06</td><td align="char" char="." valign="bottom">99</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">RR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">18</td><td align="left" valign="bottom">Diagnosis breast cancer non-registry-based study</td><td align="char" char="." valign="bottom">0.71</td><td align="char" char="." valign="bottom">0.63</td><td align="char" char="." valign="bottom">0.8</td><td align="char" char="." valign="bottom">92</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">RR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib43">Pararas et al., 2022</xref></td><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">Tis-T1 stage</td><td align="char" char="." valign="bottom">1.14</td><td align="char" char="." valign="bottom">0.87</td><td align="char" char="." valign="bottom">1.48</td><td align="char" char="." valign="bottom">41</td><td align="char" char="." valign="bottom">0.15</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">T2 stage</td><td align="char" char="." valign="bottom">0.91</td><td align="char" char="." valign="bottom">0.78</td><td align="char" char="." valign="bottom">1.06</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0.6</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">T3 stage</td><td align="char" char="." valign="bottom">1.18</td><td align="char" char="." valign="bottom">0.82</td><td align="char" char="." valign="bottom">1.7</td><td align="char" char="." valign="bottom">88</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">T4 stage</td><td align="char" char="." valign="bottom">1.19</td><td align="char" char="." valign="bottom">0.79</td><td align="char" char="." valign="bottom">1.8</td><td align="char" char="." valign="bottom">80</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">N+ stage</td><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">0.89</td><td align="char" char="." valign="bottom">1.11</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0.54</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">M+ stage</td><td align="char" char="." valign="bottom">1.65</td><td align="char" char="." valign="bottom">1.02</td><td align="char" char="." valign="bottom">2.67</td><td align="char" char="." valign="bottom">91</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">7</td><td align="left" valign="bottom">Right-sided tumors</td><td align="char" char="." valign="bottom">0.88</td><td align="char" char="." valign="bottom">0.51</td><td align="char" char="." valign="bottom">1.52</td><td align="char" char="." valign="bottom">99</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">7</td><td align="left" valign="bottom">Left-sided tumors</td><td align="char" char="." valign="bottom">0.91</td><td align="char" char="." valign="bottom">0.56</td><td align="char" char="." valign="bottom">1.5</td><td align="char" char="." valign="bottom">96</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">8</td><td align="left" valign="bottom">Rectal tumors</td><td align="char" char="." valign="bottom">0.93</td><td align="char" char="." valign="bottom">0.63</td><td align="char" char="." valign="bottom">1.37</td><td align="char" char="." valign="bottom">95</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Emergency presantations</td><td align="char" char="." valign="bottom">1.74</td><td align="char" char="." valign="bottom">1.07</td><td align="char" char="." valign="bottom">2.84</td><td align="char" char="." valign="bottom">95</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Complicated tumor</td><td align="char" char="." valign="bottom">1.72</td><td align="char" char="." valign="bottom">0.78</td><td align="char" char="." valign="bottom">3.78</td><td align="char" char="." valign="bottom">82</td><td align="char" char="." valign="bottom">0.004</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Neoadjuvant therapy</td><td align="char" char="." valign="bottom">1.22</td><td align="char" char="." valign="bottom">1.09</td><td align="char" char="." valign="bottom">1.37</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0.4</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Palliative internt surgery</td><td align="char" char="." valign="bottom">1.95</td><td align="char" char="." valign="bottom">1.13</td><td align="char" char="." valign="bottom">3.36</td><td align="char" char="." valign="bottom">54</td><td align="char" char="." valign="bottom">0.09</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">Minimally invasive surgery</td><td align="char" char="." valign="bottom">0.68</td><td align="char" char="." valign="bottom">0.37</td><td align="char" char="." valign="bottom">1.24</td><td align="char" char="." valign="bottom">98</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">Stoma formation</td><td align="char" char="." valign="bottom">0.91</td><td align="char" char="." valign="bottom">0.51</td><td align="char" char="." valign="bottom">1.62</td><td align="char" char="." valign="bottom">94</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">Morbidity</td><td align="char" char="." valign="bottom">0.92</td><td align="char" char="." valign="bottom">0.55</td><td align="char" char="." valign="bottom">1.55</td><td align="char" char="." valign="bottom">25</td><td align="char" char="." valign="bottom">0.25</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Leng of hospital stay</td><td align="char" char="." valign="bottom">0.51</td><td align="char" char="." valign="bottom">−0.93</td><td align="char" char="." valign="bottom">1.94</td><td align="char" char="." valign="bottom">79</td><td align="char" char="." valign="bottom">0.008</td><td align="left" valign="bottom">WMD<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Lymph node harvest</td><td align="char" char="." valign="bottom">1.57</td><td align="char" char="." valign="bottom">−1.99</td><td align="char" char="." valign="bottom">5.13</td><td align="char" char="." valign="bottom">64</td><td align="char" char="." valign="bottom">0.06</td><td align="left" valign="bottom">WMD<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib49">Sarich et al., 2022</xref></td><td align="char" char="." valign="bottom">12</td><td align="left" valign="bottom">Smoking prevalence</td><td align="char" char="." valign="bottom">0.87</td><td align="char" char="." valign="bottom">0.79</td><td align="char" char="." valign="bottom">0.97</td><td align="char" char="." valign="bottom">99</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">PR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">17</td><td align="left" valign="bottom">Among smokers, smoking less prevalence</td><td align="char" char="." valign="bottom">0.21</td><td align="char" char="." valign="bottom">0.14</td><td align="char" char="." valign="bottom">0.3</td><td align="char" char="." valign="bottom">99</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">Prev<xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">22</td><td align="left" valign="bottom">Among smokers, smoking more</td><td align="char" char="." valign="bottom">0.27</td><td align="char" char="." valign="bottom">0.22</td><td align="char" char="." valign="bottom">0.32</td><td align="char" char="." valign="bottom">98</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">Prev<xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">17</td><td align="left" valign="bottom">Among smokers, smoking unchanged</td><td align="char" char="." valign="bottom">0.5</td><td align="char" char="." valign="bottom">0.41</td><td align="char" char="." valign="bottom">0.58</td><td align="char" char="." valign="bottom">99</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">Prev<xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">Among smokers, quit smoking</td><td align="char" char="." valign="bottom">0.04</td><td align="char" char="." valign="bottom">0.01</td><td align="char" char="." valign="bottom">0.09</td><td align="char" char="." valign="bottom">95</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">Prev<xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Among non-smokers, started smoking</td><td align="char" char="." valign="bottom">0.02</td><td align="char" char="." valign="bottom">0.01</td><td align="char" char="." valign="bottom">0.03</td><td align="char" char="." valign="bottom">92</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">Prev<xref ref-type="table-fn" rid="table4fn2"><sup>†</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib50">Sasidharanpillai and Ravishankar, 2022</xref></td><td align="char" char="." valign="bottom">7</td><td align="left" valign="bottom">Women screened before the COVID-19 pandemic</td><td align="char" char="." valign="bottom">0.0979</td><td align="char" char="." valign="bottom">0.06</td><td align="char" char="." valign="bottom">0.1359</td><td align="char" char="." valign="bottom">100</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">Prop</td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">7</td><td align="left" valign="bottom">Women screened during the COVID-19 pandemic</td><td align="char" char="." valign="bottom">0.0424</td><td align="char" char="." valign="bottom">0.0277</td><td align="char" char="." valign="bottom">0.0571</td><td align="char" char="." valign="bottom">100</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">Prop</td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib56">Tang et al., 2022</xref></td><td align="char" char="." valign="bottom">10</td><td align="left" valign="bottom">Postoperative morbidity</td><td align="char" char="." valign="bottom">0.9</td><td align="char" char="." valign="bottom">0.8</td><td align="char" char="." valign="bottom">1.01</td><td align="char" char="." valign="bottom">26</td><td align="char" char="." valign="bottom">0.22</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">8</td><td align="left" valign="bottom">Postoperative mortality</td><td align="char" char="." valign="bottom">1.27</td><td align="char" char="." valign="bottom">0.92</td><td align="char" char="." valign="bottom">1.75</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0.57</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">Converion rate</td><td align="char" char="." valign="bottom">1.07</td><td align="char" char="." valign="bottom">0.75</td><td align="char" char="." valign="bottom">1.52</td><td align="char" char="." valign="bottom">31</td><td align="char" char="." valign="bottom">0.23</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">Incidence of anastomotic leakage</td><td align="char" char="." valign="bottom">0.71</td><td align="char" char="." valign="bottom">0.07</td><td align="char" char="." valign="bottom">19.22</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0.74</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">Intensive care unit demand rate</td><td align="char" char="." valign="bottom">0.73</td><td align="char" char="." valign="bottom">0.29</td><td align="char" char="." valign="bottom">1.85</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0.5</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">4</td><td align="left" valign="bottom">R1 resections rate</td><td align="char" char="." valign="bottom">0.46</td><td align="char" char="." valign="bottom">0.11</td><td align="char" char="." valign="bottom">1.9</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0.48</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">5</td><td align="left" valign="bottom">Mean lymph node yield</td><td align="char" char="." valign="bottom">0.16</td><td align="char" char="." valign="bottom">−2.26</td><td align="char" char="." valign="bottom">2.59</td><td align="char" char="." valign="bottom">54</td><td align="char" char="." valign="bottom">0.07</td><td align="left" valign="bottom">MD<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">7</td><td align="left" valign="bottom">Length of hospital stay</td><td align="char" char="." valign="bottom">−0.05</td><td align="char" char="." valign="bottom">−2.28</td><td align="char" char="." valign="bottom">2.19</td><td align="char" char="." valign="bottom">98</td><td align="char" char="." valign="bottom">&lt;0.001</td><td align="left" valign="bottom">MD<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib57">Teglia et al., 2022a</xref></td><td align="char" char="." valign="bottom">21</td><td align="left" valign="bottom">Breast cancer screening January–October 2020</td><td align="char" char="." valign="bottom">0.467</td><td align="char" char="." valign="bottom">0.378</td><td align="char" char="." valign="bottom">0.378</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">21</td><td align="left" valign="bottom">Breast cancer screening April 2020</td><td align="char" char="." valign="bottom">0.74</td><td align="char" char="." valign="bottom">0.567</td><td align="char" char="." valign="bottom">0.918</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">21</td><td align="left" valign="bottom">Breast cancer screening June–October 2020</td><td align="char" char="." valign="bottom">0.13</td><td align="char" char="." valign="bottom">−0.07</td><td align="char" char="." valign="bottom">0.33</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">22</td><td align="left" valign="bottom">Colorectal cancer screening January–October 2020</td><td align="char" char="." valign="bottom">0.449</td><td align="char" char="." valign="bottom">0.361</td><td align="char" char="." valign="bottom">0.538</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">21</td><td align="left" valign="bottom">Colonoscopy screening January–October 2020</td><td align="char" char="." valign="bottom">0.525</td><td align="char" char="." valign="bottom">0.388</td><td align="char" char="." valign="bottom">0.663</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">21</td><td align="left" valign="bottom">Fecal occult blood test or fecal immunochemical test January–October 2020</td><td align="char" char="." valign="bottom">0.378</td><td align="char" char="." valign="bottom">0.258</td><td align="char" char="." valign="bottom">0.499</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">21</td><td align="left" valign="bottom">Colorectal cancer screening April 2020</td><td align="char" char="." valign="bottom">0.693</td><td align="char" char="." valign="bottom">0.369</td><td align="char" char="." valign="bottom">1</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">21</td><td align="left" valign="bottom">Colorectal cancer screening June–October 2020</td><td align="char" char="." valign="bottom">0.234</td><td align="char" char="." valign="bottom">0.024</td><td align="char" char="." valign="bottom">0.444</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">11</td><td align="left" valign="bottom">Cervical cancer screening January–October 2020</td><td align="char" char="." valign="bottom">0.518</td><td align="char" char="." valign="bottom">0.389</td><td align="char" char="." valign="bottom">0.647</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">21</td><td align="left" valign="bottom">Cervical cancer screening March 2020</td><td align="char" char="." valign="bottom">0.788</td><td align="char" char="." valign="bottom">0.583</td><td align="char" char="." valign="bottom">0.993</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib58">Teglia et al., 2022b</xref></td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall treatment January–October 2020</td><td align="char" char="." valign="bottom">0.187</td><td align="char" char="." valign="bottom">0.133</td><td align="char" char="." valign="bottom">0.241</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall treatment January–February 2020</td><td align="char" char="." valign="bottom">0.027</td><td align="char" char="." valign="bottom">0.045</td><td align="char" char="." valign="bottom">0.1</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall treatment March 2020</td><td align="char" char="." valign="bottom">0.156</td><td align="char" char="." valign="bottom">0.076</td><td align="char" char="." valign="bottom">0.237</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall treatment April 2020</td><td align="char" char="." valign="bottom">0.283</td><td align="char" char="." valign="bottom">0.194</td><td align="char" char="." valign="bottom">0.372</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall treatment May 2020</td><td align="char" char="." valign="bottom">0.262</td><td align="char" char="." valign="bottom">0.176</td><td align="char" char="." valign="bottom">0.041</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall treatment June–October 2020</td><td align="char" char="." valign="bottom">0.16</td><td align="char" char="." valign="bottom">0.041</td><td align="char" char="." valign="bottom">0.279</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall surgical treatment January–October 2020</td><td align="char" char="." valign="bottom">0.339</td><td align="char" char="." valign="bottom">0.279</td><td align="char" char="." valign="bottom">0.399</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall surgical treatment January–February 2020</td><td align="char" char="." valign="bottom">0.072</td><td align="char" char="." valign="bottom">−0.093</td><td align="char" char="." valign="bottom">0.238</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall surgical treatment March 2020</td><td align="char" char="." valign="bottom">0.307</td><td align="char" char="." valign="bottom">0.219</td><td align="char" char="." valign="bottom">0.396</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall surgical treatment April 2020</td><td align="char" char="." valign="bottom">0.342</td><td align="char" char="." valign="bottom">0.239</td><td align="char" char="." valign="bottom">0.445</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall surgical treatment May 2020</td><td align="char" char="." valign="bottom">0.416</td><td align="char" char="." valign="bottom">0.318</td><td align="char" char="." valign="bottom">0.514</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall surgical treatment June–October 2020</td><td align="char" char="." valign="bottom">0.351</td><td align="char" char="." valign="bottom">0.186</td><td align="char" char="." valign="bottom">0.516</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall medical treatment January–October 2020</td><td align="char" char="." valign="bottom">0.126</td><td align="char" char="." valign="bottom">0.048</td><td align="char" char="." valign="bottom">0.204</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall medical treatment January–February 2020</td><td align="char" char="." valign="bottom">0.015</td><td align="char" char="." valign="bottom">−0.055</td><td align="char" char="." valign="bottom">0.084</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall medical treatment March 2020</td><td align="char" char="." valign="bottom">0.116</td><td align="char" char="." valign="bottom">−0.012</td><td align="char" char="." valign="bottom">0.233</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall medical treatment April 2020</td><td align="char" char="." valign="bottom">0.248</td><td align="char" char="." valign="bottom">0.09</td><td align="char" char="." valign="bottom">0.407</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall medical treatment May 2020</td><td align="char" char="." valign="bottom">0.196</td><td align="char" char="." valign="bottom">0.085</td><td align="char" char="." valign="bottom">0.306</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">Overall medical treatment June–October 2020</td><td align="char" char="." valign="bottom">0.079</td><td align="char" char="." valign="bottom">−0.078</td><td align="char" char="." valign="bottom">0.236</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib61">Vigliar et al., 2020</xref></td><td align="char" char="." valign="bottom">41</td><td align="left" valign="bottom">Cytological samples over 4 weeks of the COVID-19 pandemic</td><td align="char" char="." valign="bottom">0.453</td><td align="char" char="." valign="bottom">0.001</td><td align="char" char="." valign="bottom">0.98</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">NP</td><td align="left" valign="bottom">PRED<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">41</td><td align="left" valign="bottom">Ratio of exfoliative to fine needle aspiration samples</td><td align="char" char="." valign="bottom">0.89</td><td align="char" char="." valign="bottom">0.74</td><td align="char" char="." valign="bottom">1.08</td><td align="char" char="." valign="bottom">95</td><td align="char" char="." valign="bottom">&lt;0.01</td><td align="left" valign="bottom">OR<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr><tr><td align="left" valign="bottom"/><td align="char" char="." valign="bottom">27</td><td align="left" valign="bottom">Malignant diagnosis</td><td align="char" char="." valign="bottom">0.0556</td><td align="char" char="." valign="bottom">0.0377</td><td align="char" char="." valign="bottom">0.0735</td><td align="char" char="." valign="bottom">81</td><td align="char" char="." valign="bottom">&lt;0.01</td><td align="left" valign="bottom">RD<xref ref-type="table-fn" rid="table4fn3"><sup>‡</sup></xref></td></tr></tbody></table><table-wrap-foot><fn id="table4fn1"><label>*</label><p>Surveyed centers/operators.</p></fn><fn id="table4fn2"><label>†</label><p>Estimates are during pandemic.</p></fn><fn id="table4fn3"><label>‡</label><p>Estimates are pandemic vs. pre-pandemic.</p></fn><fn><p>LCI, lower confidence interval; IRR, incidence rate ratio; MD, mean difference; OR, odds ratio; PRED, percent reduction; PR, prevalence ratio; Prev, prevalence: Prop, proportion; RD, risk difference; RR, rate ratio; PPE, personal protective equipment; NP, not provided; UCI, upper confidence interval; SMD, standardized mean difference; WMD, weighted mean difference.</p></fn></table-wrap-foot></table-wrap><p>There were 15 reviews assessing modification of treatment (<xref ref-type="bibr" rid="bib41">Nikolopoulos et al., 2022</xref>; <xref ref-type="bibr" rid="bib19">Gascon et al., 2022</xref>; <xref ref-type="bibr" rid="bib23">Hojaij et al., 2020</xref>; <xref ref-type="bibr" rid="bib1">Adham et al., 2022</xref>; <xref ref-type="bibr" rid="bib3">Alom et al., 2021</xref>; <xref ref-type="bibr" rid="bib18">Garg et al., 2020</xref>; <xref ref-type="bibr" rid="bib37">Moujaess et al., 2020</xref>; <xref ref-type="bibr" rid="bib55">Sun et al., 2021</xref>; <xref ref-type="bibr" rid="bib13">Di Cosimo et al., 2022</xref>; <xref ref-type="bibr" rid="bib22">Hesary and Salehiniya, 2022</xref>; <xref ref-type="bibr" rid="bib33">Mazidimoradi et al., 2021</xref>; <xref ref-type="bibr" rid="bib9">Crosby and Sharma, 2020</xref>; <xref ref-type="bibr" rid="bib5">Azab and Azzam, 2021</xref>; <xref ref-type="bibr" rid="bib44">Pascual et al., 2022</xref>; <xref ref-type="bibr" rid="bib45">Piras et al., 2022</xref>). Main findings for each individual review are outlined in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref> and <xref ref-type="table" rid="table4">Table 4</xref>. All reviews were consistent reporting changes in treatment, with downscaling treatments plans in patients with cancer being a significant intervention. <xref ref-type="bibr" rid="bib13">Di Cosimo et al., 2022</xref> reported changes in treatment plans in 65% (95% CI, 53–75%; <italic>I</italic><sup>2</sup>, 98%) of centers (<xref ref-type="bibr" rid="bib13">Di Cosimo et al., 2022</xref>). Guidelines recommended use of non-surgical treatment over surgical treatments, as it was seen in head and neck cancer management. However, reviews suggested patients being assessed in a case-by-case basis and that individual factors should be considered for individualized treatment (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>). <xref ref-type="bibr" rid="bib18">Garg et al., 2020</xref> found that available guidelines were based on low level of evidence and had significant discordance for the role and timing of surgery, especially in early tumors (<xref ref-type="bibr" rid="bib18">Garg et al., 2020</xref>).</p></sec><sec id="s2-5-2"><title>Delayed and/or canceled treatment</title><p><xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref> and <xref ref-type="table" rid="table4">Table 4</xref> summarize the main findings from the 15 reviewes (<xref ref-type="bibr" rid="bib12">Dhada et al., 2021</xref>; <xref ref-type="bibr" rid="bib58">Teglia et al., 2022b</xref>; <xref ref-type="bibr" rid="bib41">Nikolopoulos et al., 2022</xref>; <xref ref-type="bibr" rid="bib17">Gadsden et al., 2022</xref>; <xref ref-type="bibr" rid="bib30">Majeed et al., 2022</xref>; <xref ref-type="bibr" rid="bib25">Jammu et al., 2021</xref>; <xref ref-type="bibr" rid="bib42">Pacheco et al., 2021</xref>; <xref ref-type="bibr" rid="bib64">Zapała et al., 2022</xref>; <xref ref-type="bibr" rid="bib13">Di Cosimo et al., 2022</xref>; <xref ref-type="bibr" rid="bib16">Ferrara et al., 2022</xref>; <xref ref-type="bibr" rid="bib28">Lignou et al., 2022</xref>; <xref ref-type="bibr" rid="bib33">Mazidimoradi et al., 2021</xref>; <xref ref-type="bibr" rid="bib46">Riera et al., 2021</xref>; <xref ref-type="bibr" rid="bib11">de Bock et al., 2022</xref>; <xref ref-type="bibr" rid="bib45">Piras et al., 2022</xref>) that assessed and reported on treatment delays and cancellations of cancer treatment. Most reviews mentioned that cancellations of treatment were observed, although to what extend this happened was not consistently provided (<xref ref-type="bibr" rid="bib25">Jammu et al., 2021</xref>; <xref ref-type="bibr" rid="bib42">Pacheco et al., 2021</xref>; <xref ref-type="bibr" rid="bib64">Zapała et al., 2022</xref>; <xref ref-type="bibr" rid="bib13">Di Cosimo et al., 2022</xref>; <xref ref-type="bibr" rid="bib16">Ferrara et al., 2022</xref>; <xref ref-type="bibr" rid="bib33">Mazidimoradi et al., 2021</xref>; <xref ref-type="bibr" rid="bib46">Riera et al., 2021</xref>). However, reviews reported that these reductions were more pronounced during a lockdown. In the meta-analysis by <xref ref-type="bibr" rid="bib57">Teglia et al., 2022a</xref>, it was found an overall reduction of −18.7% (95% CI, −13.3 to −24.1) in the total number of cancer treatments administered during January–October 2020 compared to the previous periods, with surgical treatment having a larger decrease compared to medical treatment (−33.9% versus −12.6%); among cancers, the largest decrease was observed for skin cancer (−34.7% [95% CI, −22.5 to −46.8 ]) (<xref ref-type="bibr" rid="bib58">Teglia et al., 2022b</xref>). This difference would depend on the period, with the review reporting a U-shape for the period January–October 2020. <xref ref-type="bibr" rid="bib28">Lignou et al., 2022</xref> reported that between 18th and 31st of January 2021, pediatric and noncancer surgical activities were occurring at less than a third of the rate of the previous year, while <xref ref-type="bibr" rid="bib13">Di Cosimo et al., 2022</xref> reported cancellation/delays of treatment in 58% (95%CI, 48–67%; <italic>I</italic><sup>2</sup>, 98%) of centers. <xref ref-type="bibr" rid="bib30">Majeed et al., 2022</xref> showed that shortage of treatment and delays and interruptions to cancer therapies in general were more common in low- and middle-income countries.</p></sec><sec id="s2-5-3"><title>Delayed and/or canceled screening</title><p>The results of 11 reviews (<xref ref-type="bibr" rid="bib57">Teglia et al., 2022a</xref>; <xref ref-type="bibr" rid="bib2">Alkatout et al., 2021</xref>; <xref ref-type="bibr" rid="bib15">Fancellu et al., 2022</xref>; <xref ref-type="bibr" rid="bib16">Ferrara et al., 2022</xref>; <xref ref-type="bibr" rid="bib22">Hesary and Salehiniya, 2022</xref>; <xref ref-type="bibr" rid="bib32">Mayo et al., 2021</xref>; <xref ref-type="bibr" rid="bib34">Mazidimoradi et al., 2022</xref>; <xref ref-type="bibr" rid="bib40">Ng and Hamilton, 2022</xref>; <xref ref-type="bibr" rid="bib50">Sasidharanpillai and Ravishankar, 2022</xref>; <xref ref-type="bibr" rid="bib61">Vigliar et al., 2020</xref>; <xref ref-type="bibr" rid="bib8">Bougioukas et al., 2018</xref>) reporting on cancer screening are summarized in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1e</xref> and <xref ref-type="table" rid="table4">Table 4</xref>. Of these, five included a meta-analysis. Overall, reviews showed a decline in screening rates across all cancer types, and that differences by demographic area and time periods were observed; for instance, countries that implemented lockdowns showed a higher decline in screening rates. Within colorectal and gastric cancers, most reviews reported a reduction of at least 50% in number of endoscopies and gastroscopies compared to previous years. In the meta-analysis by <xref ref-type="bibr" rid="bib57">Teglia et al., 2022a</xref>, while colorectal screening on average was reduced by 44.9% (95% CI, −53.8% to −36.1%) during January–October 2020, a U-shape association was observed. Within women-specific cancers, the meta-analyses showed a decrease in breast and cervical cancers screening rates of at least 40–50% (<xref ref-type="bibr" rid="bib57">Teglia et al., 2022a</xref>). A meta-analysis focused on cytopathology practice showed that on average there was a sample volume reduction of 45.3% (range, 0.1–98.0%), although the results would depend on the tissue sampled (<xref ref-type="bibr" rid="bib61">Vigliar et al., 2020</xref>). Similar findings were reported by <xref ref-type="bibr" rid="bib2">Alkatout et al., 2021</xref>.</p></sec><sec id="s2-5-4"><title>Reduced cancer diagnosis</title><p>Main findings of the 11 reviews (<xref ref-type="bibr" rid="bib41">Nikolopoulos et al., 2022</xref>; <xref ref-type="bibr" rid="bib30">Majeed et al., 2022</xref>; <xref ref-type="bibr" rid="bib2">Alkatout et al., 2021</xref>; <xref ref-type="bibr" rid="bib15">Fancellu et al., 2022</xref>; <xref ref-type="bibr" rid="bib16">Ferrara et al., 2022</xref>; <xref ref-type="bibr" rid="bib22">Hesary and Salehiniya, 2022</xref>; <xref ref-type="bibr" rid="bib28">Lignou et al., 2022</xref>; <xref ref-type="bibr" rid="bib33">Mazidimoradi et al., 2021</xref>; <xref ref-type="bibr" rid="bib40">Ng and Hamilton, 2022</xref>; <xref ref-type="bibr" rid="bib61">Vigliar et al., 2020</xref>; <xref ref-type="bibr" rid="bib44">Pascual et al., 2022</xref>) providing data on reduction in cancer diagnosis are provided in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1f</xref> and <xref ref-type="table" rid="table4">Table 4</xref>. Reviews were consistent in reporting decreased diagnosis of new cancer cases during the pandemic, although the reduction depended on the geographical area, the period being investigated and type of cancer. For example, there was a 73.4% decrease in cervical cancer diagnoses in Portugal during 2020, and in Italy, while there was up to 62% reduced diagnosis of colorectal cancer in 2020 compared to pre-pandemic years, the reduction was more pronounced in Northern Italy where strict lockdowns were implemented. Indeed, reviews showed that countries that implemented lockdowns measures showed the highest reduction in number of new cancer cases being diagnosed. Breast cancer diagnosis rates dropped by an estimate between 18% and 29% between 2019 and 2021 (<xref ref-type="bibr" rid="bib40">Ng and Hamilton, 2022</xref>).</p></sec><sec id="s2-5-5"><title>Reduced uptake of HPV vaccination</title><p>There was only one review to summarize data on HPV vaccination, showing up to 96% reduction in number of vaccine doses administered in March–May 2020 among adolescents and young girls aged 9–26 years; the 1-year period reduction reported was much smaller (13%) (<xref ref-type="bibr" rid="bib16">Ferrara et al., 2022</xref>).</p></sec><sec id="s2-5-6"><title>Psychological needs/distress</title><p>Thirteen reviews covered topics related to psychological needs and distress that patients with cancer experienced during the pandemic (<xref ref-type="bibr" rid="bib12">Dhada et al., 2021</xref>; <xref ref-type="bibr" rid="bib41">Nikolopoulos et al., 2022</xref>; <xref ref-type="bibr" rid="bib65">Zhang et al., 2022</xref>; <xref ref-type="bibr" rid="bib26">Kirby et al., 2022</xref>; <xref ref-type="bibr" rid="bib27">Legge et al., 2022</xref>; <xref ref-type="bibr" rid="bib4">Ayubi et al., 2021</xref>; <xref ref-type="bibr" rid="bib25">Jammu et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Momenimovahed et al., 2021</xref>; <xref ref-type="bibr" rid="bib38">Muls et al., 2022</xref>; <xref ref-type="bibr" rid="bib47">Rohilla et al., 2021</xref>; <xref ref-type="bibr" rid="bib64">Zapała et al., 2022</xref>; <xref ref-type="bibr" rid="bib22">Hesary and Salehiniya, 2022</xref>; <xref ref-type="bibr" rid="bib45">Piras et al., 2022</xref>); the findings are summarized in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1f</xref> and <xref ref-type="table" rid="table4">Table 4</xref>. Reviews reported that the pandemic negatively impacted the psychosocial and physical well-being of cancer survivors and patients with cancer experienced different levels of anxiety, depression, and insomnia. In a meta-analysis, <xref ref-type="bibr" rid="bib4">Ayubi et al., 2021</xref> reported an overall prevalence of depression and anxiety of 37% (95% CI, 27–47, <italic>I</italic><sup>2</sup>, 99.05) and 38% (95% CI, 31–46%, <italic>I</italic><sup>2</sup>, 99.08) in patients with cancer, respectively (<xref ref-type="bibr" rid="bib4">Ayubi et al., 2021</xref>). Similar findings were reported by <xref ref-type="bibr" rid="bib65">Zhang et al., 2022</xref>. Compared to controls, patients with cancer had higher anxiety level [standard mean difference (SMD 0.25 (95% CI, 0.08, 0.42)) <xref ref-type="bibr" rid="bib4">Ayubi et al., 2021</xref>].</p></sec><sec id="s2-5-7"><title>Telemedicine</title><p>Telehealth was investigated and reported in 12 of the included reviews (<xref ref-type="bibr" rid="bib12">Dhada et al., 2021</xref>; <xref ref-type="bibr" rid="bib23">Hojaij et al., 2020</xref>; <xref ref-type="bibr" rid="bib39">Murphy et al., 2022</xref>; <xref ref-type="bibr" rid="bib3">Alom et al., 2021</xref>; <xref ref-type="bibr" rid="bib29">Lu et al., 2021</xref>; <xref ref-type="bibr" rid="bib36">Mostafaei et al., 2022</xref>; <xref ref-type="bibr" rid="bib48">Salehi et al., 2022</xref>; <xref ref-type="bibr" rid="bib64">Zapała et al., 2022</xref>; <xref ref-type="bibr" rid="bib13">Di Cosimo et al., 2022</xref>; <xref ref-type="bibr" rid="bib28">Lignou et al., 2022</xref>; <xref ref-type="bibr" rid="bib44">Pascual et al., 2022</xref>; <xref ref-type="bibr" rid="bib7">Bezerra et al., 2022</xref>); a summary of main findings is provided in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h</xref>. <xref ref-type="bibr" rid="bib48">Salehi et al., 2022</xref> reported that telemedicine use in breast cancer patients was the most common investigated in studies exploring cancer-specific use of telemedicine. Telemedicine was used for various reasons, with provision of virtual visit services and consultation being the most common (<xref ref-type="bibr" rid="bib48">Salehi et al., 2022</xref>). One study explored various symptom tracking apps for patients with cancer, available in the mobile health market, and found that only a limited number of apps exist for cancer-specific symptom tracking (27%) (<xref ref-type="bibr" rid="bib29">Lu et al., 2021</xref>). In addition, of the 41 apps found, only one was tested in a clinical trial for usability among patients with cancer (<xref ref-type="bibr" rid="bib29">Lu et al., 2021</xref>). While little research exists on how patients perceived telemedicine during the COVID-19 pandemic, early data showed that majority of patients found telemedicine service helpful and that obtaining a telemedicine service helped solve their health problem. Nevertheless, there were concerns that use of telehealth for people with cancer suggests a greater proportion of missed diagnoses (<xref ref-type="bibr" rid="bib28">Lignou et al., 2022</xref>), and that telemedicine cannot be a substitute for face-to-face appointments (<xref ref-type="bibr" rid="bib36">Mostafaei et al., 2022</xref>).</p></sec><sec id="s2-5-8"><title>Financial distress and social isolation</title><p>Five reviews reported the economic impact of COVID-19 and social isolation of patients with cancer during the pandemic (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1i</xref>; <xref ref-type="bibr" rid="bib12">Dhada et al., 2021</xref>; <xref ref-type="bibr" rid="bib26">Kirby et al., 2022</xref>; <xref ref-type="bibr" rid="bib27">Legge et al., 2022</xref>; <xref ref-type="bibr" rid="bib25">Jammu et al., 2021</xref>; <xref ref-type="bibr" rid="bib45">Piras et al., 2022</xref>). While there is little research on this topic, overall, the reviews suggested financial distress with direct and indirect costs burden and social isolation being a common issue for patients with cancer. Reviews also were consistent in reporting social isolation and loneliness among patients with cancer. Several factors contributed to social isolation, including fear of infection, social distancing measures, not having visitors and lack of social interaction during treatment.</p></sec><sec id="s2-5-9"><title>Tobacco use and cessation</title><p>There was only one systematic review and meta-analysis to explore tobacco use and cessation during the pandemic (<xref ref-type="bibr" rid="bib49">Sarich et al., 2022</xref>). Based on data from 31 studies, <xref ref-type="bibr" rid="bib49">Sarich et al., 2022</xref> found that, compared to pre-pandemic period, the proportion of people smoking during the pandemic was lower (pooled prevalence ratio of 0·87 (95%CI, 0·79–0·97)). In addition, there was similar proportions among smokers before pandemic who smoked more or smoked less during the pandemic, and on average 4% (95% CI, 1–9%) reported stopping smoking. 2% reported starting smoking during the pandemic. High heterogeneity was observed across the meta-analyses results.</p></sec><sec id="s2-5-10"><title>Other aspects of cancer care</title><p>Eighteen reviews (<xref ref-type="bibr" rid="bib14">Donkor et al., 2021</xref>; <xref ref-type="bibr" rid="bib19">Gascon et al., 2022</xref>; <xref ref-type="bibr" rid="bib23">Hojaij et al., 2020</xref>; <xref ref-type="bibr" rid="bib17">Gadsden et al., 2022</xref>; <xref ref-type="bibr" rid="bib30">Majeed et al., 2022</xref>; <xref ref-type="bibr" rid="bib1">Adham et al., 2022</xref>; <xref ref-type="bibr" rid="bib3">Alom et al., 2021</xref>; <xref ref-type="bibr" rid="bib37">Moujaess et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Pacheco et al., 2021</xref>; <xref ref-type="bibr" rid="bib47">Rohilla et al., 2021</xref>; <xref ref-type="bibr" rid="bib13">Di Cosimo et al., 2022</xref>; <xref ref-type="bibr" rid="bib28">Lignou et al., 2022</xref>; <xref ref-type="bibr" rid="bib43">Pararas et al., 2022</xref>; <xref ref-type="bibr" rid="bib56">Tang et al., 2022</xref>; <xref ref-type="bibr" rid="bib59">Thomson et al., 2020</xref>; <xref ref-type="bibr" rid="bib11">de Bock et al., 2022</xref>; <xref ref-type="bibr" rid="bib44">Pascual et al., 2022</xref>) reported on mitigations strategies and cancer service restructuring, impact of measures on cancer prognosis, and on quality of recommendations provided during COVID-19 for cancer care; findings are summarized in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1j</xref>. In the meta-analysis by <xref ref-type="bibr" rid="bib13">Di Cosimo et al., 2022</xref> routine use of PPE by patient and healthcare personnel was reported by 81% and 80% of centers, respectively; systematic SARS-CoV-2 screening by nasopharyngeal swabs was reported by only 41% of centers (<xref ref-type="bibr" rid="bib13">Di Cosimo et al., 2022</xref>). Five reviews also reported on potential impact of mitigation strategies on cancer outcomes/prognosis (<xref ref-type="bibr" rid="bib2">Alkatout et al., 2021</xref>; <xref ref-type="bibr" rid="bib28">Lignou et al., 2022</xref>; <xref ref-type="bibr" rid="bib43">Pararas et al., 2022</xref>; <xref ref-type="bibr" rid="bib56">Tang et al., 2022</xref>; <xref ref-type="bibr" rid="bib11">de Bock et al., 2022</xref>). It was estimated that 59,204–63,229 years of life lost might be attributable to delays in cancer diagnosis alone because of the first COVID-19 lockdown in the UK, albeit the findings were based on single study. Delayed cancer screening was estimated to cause globally the following additional numbers of cancer deaths secondary to breast, esophageal, lung, and colorectal cancer, respectively: 54,112–65,756, 31,556–32,644, 86,214–95,195, and 143,081–155,238 (<xref ref-type="bibr" rid="bib2">Alkatout et al., 2021</xref>). <xref ref-type="bibr" rid="bib56">Tang et al., 2022</xref>, <xref ref-type="bibr" rid="bib11">de Bock et al., 2022</xref> found no deterioration in the surgical outcomes of all types of cancer or colorectal cancer surgery: also no reduction in the quality of cancer removal was observed. Similar findings were also reported by <xref ref-type="bibr" rid="bib43">Pararas et al., 2022</xref>, despite the number of patients presenting with metastases during the pandemic was significantly increased. <xref ref-type="bibr" rid="bib59">Thomson et al., 2020</xref>, by exploring recommendations for hypofractionated radiation therapy, found that in general the recommendations during the pandemic were based on lower quality of evidence than the highest quality routinely used dose fractionation schedules.</p></sec></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The current umbrella review summarized and appraised systematically the evidence on the extent to which several aspects of cancer care were disrupted during the COVID-19 pandemic. The summary message provided by 51 systematic reviews is that there have been modifications, delays and cancellation of treatment, delays and cancellation in cancer screening and diagnosis, and patients with cancer may have experienced additional psychological, social, and financial distress. Nevertheless, appraisal of the impact of COVID-19 on cancer care is mainly based on limited and low-quality evidence, and that data mainly derive from high-income countries, with little understanding of consequences of COVID-19 on cancer care in low- and middle-income countries. In addition, limited evidence exists on whether disruptions in cancer care during the pandemic had adverse impact in prognosis of patients with cancer and mortality.</p><p>Several guidelines were provided for cancer care during the pandemic, including recommendations on mitigation strategies to prevent SARS-CoV-2 infection and cancer treatment modalities. Nevertheless, most recommendations were based on expert opinions, and little quantitative evidence was provided to support them. This aspect was highlighted also in the systematic review by <xref ref-type="bibr" rid="bib59">Thomson et al., 2020</xref>. The authors explored recommendations for hypofranctionated radiation therapy before and during pandemic and found that during the pandemic there was a significant shift from established higher-quality evidence to lower-quality evidence and expert opinions for the recommended hypofractionated radiation schedules. Similar findings were reported also by <xref ref-type="bibr" rid="bib18">Garg et al., 2020</xref>, suggesting not only guidelines were based on low level of evidence, but also there was significant discordance for the role and timing of surgery, especially in early tumors.</p><p>Specific recommendations established from the guidelines such as prioritization of high-grade malignancy, as well as other aspects such as lockdowns, social restrictions, restructure of cancer care with prioritization of high-risk malignancies and use of telemedicine, fear of infection, financial distress and shortage in medications could explain the delays and cancellation in cancer treatment, screening, and diagnosis reported in several studies. For example, <xref ref-type="bibr" rid="bib28">Lignou et al., 2022</xref> raised concerns that use of telehealth for people with cancer suggests a greater proportion of missed diagnoses. Most of examined systematic reviews reported a substantial reduction in treatment, screening, and diagnosis of several cancers during the pandemic, which was more pronounced for countries that implemented a lockdown. In addition, differences were observed by geographical area, suggesting that the impact on cancer treatment, screening and diagnosis could depend on mitigation strategies countries implemented as well as on country-specific healthcare organization and resources. For example, shortage of treatment and delays and interruptions to cancer therapies in general were more pronounced in low- and middle-income countries (<xref ref-type="bibr" rid="bib30">Majeed et al., 2022</xref>). The findings on disruption of cancer treatment, screening, and diagnosis are in line with findings reported for other chronic diseases, such as cardiovascular disease (<xref ref-type="bibr" rid="bib63">Williams et al., 2021</xref>), suggesting the adverse impact might not be cancer specific. Future research should explore and compare how different chronic diseases were impacted.</p><p>Evidence is limited on evaluating how disruption of cancer care during COVID-19 affected prognosis of patients with cancer. Limited evidence showed that the number of patients presenting with metastases during the pandemic was significantly increased, and emergency presentations and palliative surgeries were more frequent during the pandemic (<xref ref-type="bibr" rid="bib43">Pararas et al., 2022</xref>). No deterioration in the surgical outcomes of colorectal cancer surgery including mortality or reduction in the quality of cancer removal was observed (<xref ref-type="bibr" rid="bib43">Pararas et al., 2022</xref>; <xref ref-type="bibr" rid="bib56">Tang et al., 2022</xref>). A study (<xref ref-type="bibr" rid="bib31">Maringe et al., 2020</xref>) in UK estimated that 59,204–63,229 years of life lost might be attributable to delays in cancer diagnosis alone because of the first COVID-19 lockdown, but estimates were based on modeling. Several studies <xref ref-type="bibr" rid="bib10">Cui et al., 2022</xref>; <xref ref-type="bibr" rid="bib52">Smith et al., 2021</xref> have shown a decline in elective cancer such as colorectal cancer, despite findings showing that gastrointestinal cancer surgery during pandemic is safe with appropriate isolation measures and no delays should be implemented for both early and advanced cancer (<xref ref-type="bibr" rid="bib53">Sozutek et al., 2021</xref>). A recent meta-analysis (<xref ref-type="bibr" rid="bib62">Whittaker et al., 2021</xref>) showed that delaying colorectal cancer longer than 4 weeks could be associated with poorer outcomes.</p><p>Several studies and systematic reviews thereof have investigated the impact of the pandemic on psychological well-being, financial distress, and social isolation of patients with cancer, as well as the role of telemedicine in cancer care. While studies suggested depression, anxiety, post-traumatic disorder, insomnia, and fear of cancer progression being highly reported by cancer patients with estimates reaching beyond 50%, high heterogeneity was observed, and in general systemic analysis comparing the findings with pre-pandemic period rates was lacking. The pandemic was reported to have financial burden on cancer patients with direct and indirect costs. Social isolation was commonly reported and mainly driven by fear of infection, social distancing measures, and lack of social interaction during treatment. Nevertheless, there was limited effort to quantify social isolation and economic impact on cancer care. Telemedicine and remote consultations were sharply increased in use for different aspects of cancer care, including treatment, screening, and rehabilitation. However, evidence is limited in evaluating and quantifying the positive and negative impact, as well as cost-effectiveness of telemedicine. While limited evidence suggested telemedicine reduced costs of cancer care for both patients and healthcare provider, there were concerns especially from patients that telemedicine could not have similar benefits to on-site consultations.</p><p>Our study has certain limitations. Although our search was based on recent recommendations on optimal databases needed to be searched for umbrella reviews (<xref ref-type="bibr" rid="bib21">Goossen et al., 2020</xref>), we cannot rule out missing some other relevant systematic reviews. Most systematic reviews included in this umbrella review were based on intermediate and high risk of bias studies, and the findings were mainly based on case-series, cross-sectional and retrospective observational study designs which are prone to residual confounding and poor in determining temporal associations. Prevalence and incidence estimates are also subject to selection biases. In some instances, data were derived from one study or from studies with small sample sizes and limited number of events, leading to large uncertainty. Many studies did not include any pre-pandemic controls. Furthermore, some of the evidence overlapped among the systematic reviews that were included in this umbrella review, but this allows comparing notes on results and conclusions for the overlapping efforts. Some systematic reviews were published early (in 2020), and thus they had even more limited evidence and the impact of the disruptions may have differed across different pandemic waves. Most findings were derived from high-income and/or western countries, limiting the generalizability of the findings to low- and middle-income countries. Lastly, concreate conclusions on intermediate, and long-term impact remain unclear. Finally, the suboptimal methodological rigor of many included reviews is notable.</p><p>In summary, evidence shows a diverse and substantial impact of the COVID-19 pandemic on cancer care, including delays in treatment, screening, and diagnosis. Also, patients with cancer had been affected psychologically, socially, and financially during the COVID-19 crisis. However, large uncertainty and gaps exist in the literature on this topic. Most of the evidence on the topic is derived mainly from high- and middle-income countries, and low-quality studies, and thus, future high-quality studies with larger geographical capture and properly performed, rigorous systematic reviews with careful meta-analyses will continue to have value in this field.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><p>We performed an umbrella review following the recent published guideline (<xref ref-type="bibr" rid="bib6">Belbasis et al., 2022</xref>), and for reporting we adhered to the Preferred Reporting Items for Overviews of Reviews – PRIOR checklist (<xref ref-type="bibr" rid="bib20">Gates et al., 2022</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1k</xref>). The protocol has been registered with the Open Science Framework (<ext-link ext-link-type="uri" xlink:href="https://osf.io/qjgxv">https://osf.io/qjgxv</ext-link>).</p><sec id="s4-1"><title>Search strategy</title><p>Literature search was performed in PubMed and WHO COVID-19 database using the search strategy in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1l</xref>. No language restriction was applied. We searched for studies published until November 3, 2022; an update of the search was performed until November 29, 2022. References cited in the final included studies for analysis were further screened to identify other relevant publications.</p></sec><sec id="s4-2"><title>Screening, study selection, and eligibility criteria</title><p>Retrieved items were first screened based on the title and abstract and potentially eligible references were then screened in full text. Screening was performed by two reviewers and in case of discrepancies, a final decision to include or exclude was settled with discussion. We included studies if they fulfilled all the following criteria: (1) were systematic reviews with our without meta-analysis or individual participant meta-analysis; (2) included individuals diagnosed with any type of cancer and at any cancer stages (early to advanced), or individuals targeted for cancer screening; (3) assessed the impact of the COVID-19 pandemic, and thus had data collected during the pandemic period (2020–2022) (the included studies may nevertheless have used also control pre-pandemic periods in order to assess the magnitude of change during the pandemic); and assessed any of the following outcomes: delay/cancellation of treatment (overall and per specific treatment); modification of treatment (overall and per specific treatment); delayed/canceled screening (overall and per specific type of screening); reduced diagnoses (overall and per specific diagnosis); psychological needs; ethical needs; social needs; financial burden and distress; social impact/isolation; psychological distress; use of telehealth/virtual visits, and other aspects of cancer care such as impact of the COVID-19 pandemic on prognosis. In addition, irrespective of including patients with cancer, we included reviews that looked at impact of COVID-19 on uptake of HPV vaccination and tobacco use and cessation.</p></sec><sec id="s4-3"><title>Data extraction and critical appraisal</title><p>The data extraction was performed by one of the authors and the extracted data were further checked by two other authors; differences were settled by discussion. In case an eligible article included data from several diseases, when feasible, we extracted information only on cancer-related outcomes of our interest. First, we extracted general information from the eligible reviews, including information on authors, year of publication, type of studies considered (design), number of eligible studies, COVID-19 period covered (until when), whether it has considered studies with pre-pandemic controls (yes exclusively/yes for some/not at all), the outcomes examined and for which cancers each outcome was examined, and methods of analysis and heterogeneity (if provided). To provide the geographical breadth of the evidence, we extracted information on location(s) of the individual studies included in the eligible reviews; for example, retrieving information on countries and areas or whether the studies were done in multiple countries. Concerning the methodological rigor, for each systematic review we extracted information on whether the authors used any previously validated tool or any other set of extracted items to assess the methodological rigor of the included studies. If yes, we recorded the tool used and the main conclusions of the assessment were grouped in the broad categories: most studies were weak in methodological rigor, most studies were strong in methodological rigor, or mixed/intermediate pattern between the other two categories. Two reviewers assessed methodological rigor of the included systematic reviews using the AMSTAR-2 tool (<xref ref-type="bibr" rid="bib51">Shea et al., 2017</xref>); any discrepancies were settled with the help of a third reviewer. AMSTAR-2 is based on a 16 item or domain checklist, with seven of these items considered critical for the overall validity of a review. The domains considered critical are: (1) protocol registration before starting the review; (2) adequate and comprehensive search of the literature; (3) providing justification for the exclusion of individual studies; (4) risk of bias assessment of the studies included in the review; (5) use of appropriate statistical methods in performing a meta-analysis; (6) accounting for risk of bias when interpreting the results; (7) evaluation of the presence and impact of publication bias. Last, based on abstract and full-text reading, we extracted information on main conclusions derived from each of the included reviews. When the review included several disease areas, we extracted information on main findings of the included individual studies within the review that were relevant to cancer.</p></sec><sec id="s4-4"><title>Statistical analysis</title><p>Due to high heterogeneity in the designs, study questions, outcomes, and metrics, a descriptive analysis was performed. We calculated the proportion of reviews that provided information on single countries and multiple countries. Median and interquartile range were calculated for some of the characteristics of the eligible reviews (e.g., number of databases searched). Separate tables were created for the methodological appraisal of the systematic reviews, the methodological appraisal of the studies in each systematic review, for the characteristics and subject matter information of each systematic review, and for the final conclusions of each systematic review. In addition, we created a separate table for reviews that implemented meta-analysis, providing the summary estimates, 95% CIs, and heterogeneity estimates. Limitations and areas of limited evidence were noted.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Data curation, Formal analysis, Supervision, Validation, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>(1a-l) Table characteristics, main findings, PRISMA, and search strategy.</title></caption><media xlink:href="elife-85679-supp1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Bibliographic databases used from each review (see excel file).</title></caption><media xlink:href="elife-85679-supp2-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-85679-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data are in the manuscript and supplements.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We would like to thank Beatrice Minder for helping with search strategy and Dr. Erand Llanaj (Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany) for designing and illustrating the graphical abstract.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adham</surname><given-names>M</given-names></name><name><surname>Anam</surname><given-names>K</given-names></name><name><surname>Reksodiputro</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Treatment prioritization and risk stratification of head and neck cancer during COVID-19 pandemic: a systematic review</article-title><source>The Medical Journal of Malaysia</source><volume>77</volume><fpage>53</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">35086995</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkatout</surname><given-names>I</given-names></name><name><surname>Biebl</surname><given-names>M</given-names></name><name><surname>Momenimovahed</surname><given-names>Z</given-names></name><name><surname>Giovannucci</surname><given-names>E</given-names></name><name><surname>Hadavandsiri</surname><given-names>F</given-names></name><name><surname>Salehiniya</surname><given-names>H</given-names></name><name><surname>Allahqoli</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Has COVID-19 affected cancer screening programs? A systematic review</article-title><source>Frontiers in Oncology</source><volume>11</volume><elocation-id>675038</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2021.675038</pub-id><pub-id pub-id-type="pmid">34079764</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alom</surname><given-names>S</given-names></name><name><surname>Chiu</surname><given-names>CM</given-names></name><name><surname>Jha</surname><given-names>A</given-names></name><name><surname>Lai</surname><given-names>SHD</given-names></name><name><surname>Yau</surname><given-names>THL</given-names></name><name><surname>Harky</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The effects of COVID-19 on cancer care provision: a systematic review</article-title><source>Cancer Control</source><volume>28</volume><elocation-id>1073274821997425</elocation-id><pub-id pub-id-type="doi">10.1177/1073274821997425</pub-id><pub-id pub-id-type="pmid">33631953</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayubi</surname><given-names>E</given-names></name><name><surname>Bashirian</surname><given-names>S</given-names></name><name><surname>Khazaei</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Depression and anxiety among patients with cancer during COVID-19 pandemic: a systematic review and meta-analysis</article-title><source>Journal of Gastrointestinal Cancer</source><volume>52</volume><fpage>499</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1007/s12029-021-00643-9</pub-id><pub-id pub-id-type="pmid">33950368</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azab</surname><given-names>MA</given-names></name><name><surname>Azzam</surname><given-names>AY</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Impact of COVID-19 pandemic on the management of glioma patients around the world: An evidence-based review</article-title><source>Brain Disorders</source><volume>2</volume><elocation-id>100012</elocation-id><pub-id pub-id-type="doi">10.1016/j.dscb.2021.100012</pub-id><pub-id pub-id-type="pmid">33997826</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belbasis</surname><given-names>L</given-names></name><name><surname>Bellou</surname><given-names>V</given-names></name><name><surname>Ioannidis</surname><given-names>JPA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Conducting umbrella reviews</article-title><source>BMJ Medicine</source><volume>1</volume><elocation-id>e000071</elocation-id><pub-id pub-id-type="doi">10.1136/bmjmed-2021-000071</pub-id><pub-id pub-id-type="pmid">36936579</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bezerra</surname><given-names>GMF</given-names></name><name><surname>de Lucena Feitosa</surname><given-names>ES</given-names></name><name><surname>Vale Catunda</surname><given-names>JG</given-names></name><name><surname>Nogueira Sales Graça</surname><given-names>C</given-names></name><name><surname>Lucena de Aquino</surname><given-names>P</given-names></name><name><surname>Bezerra Neto</surname><given-names>AG</given-names></name><name><surname>Bezerra da Silva Junior</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Telemedicine application and assessment during the COVID-19 pandemic</article-title><source>Studies in Health Technology and Informatics</source><volume>290</volume><fpage>854</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.3233/SHTI220200</pub-id><pub-id pub-id-type="pmid">35673139</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bougioukas</surname><given-names>KI</given-names></name><name><surname>Liakos</surname><given-names>A</given-names></name><name><surname>Tsapas</surname><given-names>A</given-names></name><name><surname>Ntzani</surname><given-names>E</given-names></name><name><surname>Haidich</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms</article-title><source>Journal of Clinical Epidemiology</source><volume>93</volume><fpage>9</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2017.10.002</pub-id><pub-id pub-id-type="pmid">29037888</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crosby</surname><given-names>DL</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Evidence-Based guidelines for management of head and neck mucosal malignancies during the COVID-19 pandemic</article-title><source>Otolaryngology--Head and Neck Surgery</source><volume>163</volume><fpage>16</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1177/0194599820923623</pub-id><pub-id pub-id-type="pmid">32340549</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>An</surname><given-names>Q</given-names></name><name><surname>Xiao</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Impact of the COVID-19 pandemic on elective surgery for colorectal cancer</article-title><source>Journal of Gastrointestinal Cancer</source><volume>53</volume><fpage>403</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1007/s12029-021-00621-1</pub-id><pub-id pub-id-type="pmid">33730339</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Bock</surname><given-names>E</given-names></name><name><surname>Herman</surname><given-names>ES</given-names></name><name><surname>Bastian</surname><given-names>OW</given-names></name><name><surname>Filipe</surname><given-names>MD</given-names></name><name><surname>Vriens</surname><given-names>MR</given-names></name><name><surname>Richir</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Systematic review and meta-analysis determining the effect of implemented COVID-19 guidelines on surgical oncology volumes and clinical outcomes</article-title><source>Surgical Oncology</source><volume>45</volume><elocation-id>101859</elocation-id><pub-id pub-id-type="doi">10.1016/j.suronc.2022.101859</pub-id><pub-id pub-id-type="pmid">36242979</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhada</surname><given-names>S</given-names></name><name><surname>Stewart</surname><given-names>D</given-names></name><name><surname>Cheema</surname><given-names>E</given-names></name><name><surname>Hadi</surname><given-names>MA</given-names></name><name><surname>Paudyal</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cancer services during the COVID-19 pandemic: systematic review of patient’s and caregiver’s experiences</article-title><source>Cancer Management and Research</source><volume>13</volume><fpage>5875</fpage><lpage>5887</lpage><pub-id pub-id-type="doi">10.2147/CMAR.S318115</pub-id><pub-id pub-id-type="pmid">34349561</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Cosimo</surname><given-names>S</given-names></name><name><surname>Susca</surname><given-names>N</given-names></name><name><surname>Apolone</surname><given-names>G</given-names></name><name><surname>Silvestris</surname><given-names>N</given-names></name><name><surname>Racanelli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The worldwide impact of COVID-19 on cancer care: a meta-analysis of surveys published after the first wave of the pandemic</article-title><source>Frontiers in Oncology</source><volume>12</volume><elocation-id>961380</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2022.961380</pub-id><pub-id pub-id-type="pmid">36249038</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donkor</surname><given-names>A</given-names></name><name><surname>Atuwo-Ampoh</surname><given-names>VD</given-names></name><name><surname>Opie</surname><given-names>C</given-names></name><name><surname>Yakanu</surname><given-names>F</given-names></name><name><surname>Lombe</surname><given-names>D</given-names></name><name><surname>Khader</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Novel coronavirus mitigation measures implemented by radiotherapy centres in low and middle-income countries: a systematic review</article-title><source>Reports of Practical Oncology and Radiotherapy</source><volume>26</volume><fpage>303</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.5603/RPOR.a2021.0032</pub-id><pub-id pub-id-type="pmid">34211781</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fancellu</surname><given-names>A</given-names></name><name><surname>Veneroni</surname><given-names>S</given-names></name><name><surname>Santoru</surname><given-names>A</given-names></name><name><surname>Meloni</surname><given-names>A</given-names></name><name><surname>Sanna</surname><given-names>V</given-names></name><name><surname>Ginesu</surname><given-names>GC</given-names></name><name><surname>Deiana</surname><given-names>G</given-names></name><name><surname>Paliogiannis</surname><given-names>P</given-names></name><name><surname>Ninniri</surname><given-names>C</given-names></name><name><surname>Perra</surname><given-names>T</given-names></name><name><surname>Porcu</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>How the COVID-19 pandemic has affected the colorectal cancer screening in Italy: a minireview</article-title><source>World Journal of Gastrointestinal Oncology</source><volume>14</volume><fpage>1490</fpage><lpage>1498</lpage><pub-id pub-id-type="doi">10.4251/wjgo.v14.i8.1490</pub-id><pub-id pub-id-type="pmid">36160740</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrara</surname><given-names>P</given-names></name><name><surname>Dallagiacoma</surname><given-names>G</given-names></name><name><surname>Alberti</surname><given-names>F</given-names></name><name><surname>Gentile</surname><given-names>L</given-names></name><name><surname>Bertuccio</surname><given-names>P</given-names></name><name><surname>Odone</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Prevention, diagnosis and treatment of cervical cancer: a systematic review of the impact of COVID-19 on patient care</article-title><source>Preventive Medicine</source><volume>164</volume><elocation-id>107264</elocation-id><pub-id pub-id-type="doi">10.1016/j.ypmed.2022.107264</pub-id><pub-id pub-id-type="pmid">36150446</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gadsden</surname><given-names>T</given-names></name><name><surname>Downey</surname><given-names>LE</given-names></name><name><surname>Vilas</surname><given-names>VDR</given-names></name><name><surname>Peiris</surname><given-names>D</given-names></name><name><surname>Jan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The impact of COVID-19 on essential health service provision for noncommunicable diseases in the south-east asia region: a systematic review</article-title><source>The Lancet Regional Health. Southeast Asia</source><volume>1</volume><elocation-id>100010</elocation-id><pub-id pub-id-type="doi">10.1016/j.lansea.2022.04.006</pub-id><pub-id pub-id-type="pmid">35769108</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garg</surname><given-names>PK</given-names></name><name><surname>Kaul</surname><given-names>P</given-names></name><name><surname>Choudhary</surname><given-names>D</given-names></name><name><surname>Turaga</surname><given-names>KK</given-names></name><name><surname>Singh</surname><given-names>MP</given-names></name><name><surname>Tiwari</surname><given-names>AR</given-names></name><name><surname>Arora</surname><given-names>V</given-names></name><name><surname>Agrawal</surname><given-names>N</given-names></name><name><surname>Rau</surname><given-names>B</given-names></name><name><surname>Yendamuri</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Discordance of COVID-19 guidelines for patients with cancer: a systematic review</article-title><source>Journal of Surgical Oncology</source><volume>122</volume><fpage>579</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1002/jso.26110</pub-id><pub-id pub-id-type="pmid">32668034</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gascon</surname><given-names>L</given-names></name><name><surname>Fournier</surname><given-names>I</given-names></name><name><surname>Chiesa-Estomba</surname><given-names>C</given-names></name><name><surname>Russo</surname><given-names>G</given-names></name><name><surname>Fakhry</surname><given-names>N</given-names></name><name><surname>Lechien</surname><given-names>JR</given-names></name><name><surname>Burnell</surname><given-names>L</given-names></name><name><surname>Vergez</surname><given-names>S</given-names></name><name><surname>Metwaly</surname><given-names>O</given-names></name><name><surname>Capasso</surname><given-names>P</given-names></name><name><surname>Ayad</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Systematic review of international guidelines for head and neck oncology management in COVID-19 patients</article-title><source>European Archives of Oto-Rhino-Laryngology</source><volume>279</volume><fpage>907</fpage><lpage>943</lpage><pub-id pub-id-type="doi">10.1007/s00405-021-06823-4</pub-id><pub-id pub-id-type="pmid">33891167</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gates</surname><given-names>M</given-names></name><name><surname>Gates</surname><given-names>A</given-names></name><name><surname>Pieper</surname><given-names>D</given-names></name><name><surname>Fernandes</surname><given-names>RM</given-names></name><name><surname>Tricco</surname><given-names>AC</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Brennan</surname><given-names>SE</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Pollock</surname><given-names>M</given-names></name><name><surname>Lunny</surname><given-names>C</given-names></name><name><surname>Sepúlveda</surname><given-names>D</given-names></name><name><surname>McKenzie</surname><given-names>JE</given-names></name><name><surname>Scott</surname><given-names>SD</given-names></name><name><surname>Robinson</surname><given-names>KA</given-names></name><name><surname>Matthias</surname><given-names>K</given-names></name><name><surname>Bougioukas</surname><given-names>KI</given-names></name><name><surname>Fusar-Poli</surname><given-names>P</given-names></name><name><surname>Whiting</surname><given-names>P</given-names></name><name><surname>Moss</surname><given-names>SJ</given-names></name><name><surname>Hartling</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement</article-title><source>BMJ</source><volume>378</volume><elocation-id>e070849</elocation-id><pub-id pub-id-type="doi">10.1136/bmj-2022-070849</pub-id><pub-id pub-id-type="pmid">35944924</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goossen</surname><given-names>K</given-names></name><name><surname>Hess</surname><given-names>S</given-names></name><name><surname>Lunny</surname><given-names>C</given-names></name><name><surname>Pieper</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Database combinations to retrieve systematic reviews in overviews of reviews: a methodological study</article-title><source>BMC Medical Research Methodology</source><volume>20</volume><elocation-id>138</elocation-id><pub-id pub-id-type="doi">10.1186/s12874-020-00983-3</pub-id><pub-id pub-id-type="pmid">32487023</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hesary</surname><given-names>FB</given-names></name><name><surname>Salehiniya</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The impact of the COVID-19 epidemic on diagnosis, treatment, concerns, problems, and mental health in patients with gastric cancer</article-title><source>Journal of Gastrointestinal Cancer</source><volume>53</volume><fpage>797</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1007/s12029-021-00692-0</pub-id><pub-id pub-id-type="pmid">34519975</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hojaij</surname><given-names>FC</given-names></name><name><surname>Chinelatto</surname><given-names>LA</given-names></name><name><surname>Boog</surname><given-names>GHP</given-names></name><name><surname>Kasmirski</surname><given-names>JA</given-names></name><name><surname>Lopes</surname><given-names>JVZ</given-names></name><name><surname>Medeiros</surname><given-names>VMB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Head and neck practice in the COVID-19 pandemics today: a rapid systematic review</article-title><source>International Archives of Otorhinolaryngology</source><volume>24</volume><fpage>e518</fpage><lpage>e526</lpage><pub-id pub-id-type="doi">10.1055/s-0040-1715506</pub-id><pub-id pub-id-type="pmid">33101521</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoy</surname><given-names>D</given-names></name><name><surname>Brooks</surname><given-names>P</given-names></name><name><surname>Woolf</surname><given-names>A</given-names></name><name><surname>Blyth</surname><given-names>F</given-names></name><name><surname>March</surname><given-names>L</given-names></name><name><surname>Bain</surname><given-names>C</given-names></name><name><surname>Baker</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>E</given-names></name><name><surname>Buchbinder</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement</article-title><source>Journal of Clinical Epidemiology</source><volume>65</volume><fpage>934</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2011.11.014</pub-id><pub-id pub-id-type="pmid">22742910</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jammu</surname><given-names>AS</given-names></name><name><surname>Chasen</surname><given-names>MR</given-names></name><name><surname>Lofters</surname><given-names>AK</given-names></name><name><surname>Bhargava</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Systematic rapid living review of the impact of the COVID-19 pandemic on cancer survivors: update to August 27, 2020</article-title><source>Supportive Care in Cancer</source><volume>29</volume><fpage>2841</fpage><lpage>2850</lpage><pub-id pub-id-type="doi">10.1007/s00520-020-05908-w</pub-id><pub-id pub-id-type="pmid">33242162</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirby</surname><given-names>A</given-names></name><name><surname>Drummond</surname><given-names>FJ</given-names></name><name><surname>Lawlor</surname><given-names>A</given-names></name><name><surname>Murphy</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Counting the social, psychological, and economic costs of COVID-19 for cancer patients</article-title><source>Supportive Care in Cancer</source><volume>30</volume><fpage>8705</fpage><lpage>8731</lpage><pub-id pub-id-type="doi">10.1007/s00520-022-07178-0</pub-id><pub-id pub-id-type="pmid">35690662</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Legge</surname><given-names>H</given-names></name><name><surname>Toohey</surname><given-names>K</given-names></name><name><surname>Kavanagh</surname><given-names>PS</given-names></name><name><surname>Paterson</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The unmet supportive care needs of people affected by cancer during the COVID-19 pandemic: an integrative review</article-title><source>Journal of Cancer Survivorship</source><volume>2022</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1007/s11764-022-01275-z</pub-id><pub-id pub-id-type="pmid">36307612</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lignou</surname><given-names>S</given-names></name><name><surname>Greenwood</surname><given-names>J</given-names></name><name><surname>Sheehan</surname><given-names>M</given-names></name><name><surname>Wolfe</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Changes in healthcare provision during covid-19 and their impact on children with chronic illness: a scoping review</article-title><source>Inquiry</source><volume>59</volume><elocation-id>469580221081445</elocation-id><pub-id pub-id-type="doi">10.1177/00469580221081445</pub-id><pub-id pub-id-type="pmid">35345920</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>DJ</given-names></name><name><surname>Girgis</surname><given-names>M</given-names></name><name><surname>David</surname><given-names>JM</given-names></name><name><surname>Chung</surname><given-names>EM</given-names></name><name><surname>Atkins</surname><given-names>KM</given-names></name><name><surname>Kamrava</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Evaluation of mobile health applications to track patient-reported outcomes for oncology patients: a systematic review</article-title><source>Advances in Radiation Oncology</source><volume>6</volume><elocation-id>100576</elocation-id><pub-id pub-id-type="doi">10.1016/j.adro.2020.09.016</pub-id><pub-id pub-id-type="pmid">33073061</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majeed</surname><given-names>A</given-names></name><name><surname>Wright</surname><given-names>T</given-names></name><name><surname>Guo</surname><given-names>B</given-names></name><name><surname>Arora</surname><given-names>RS</given-names></name><name><surname>Lam</surname><given-names>CG</given-names></name><name><surname>Martiniuk</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The global impact of COVID-19 on childhood cancer outcomes and care delivery - a systematic review</article-title><source>Frontiers in Oncology</source><volume>12</volume><elocation-id>869752</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2022.869752</pub-id><pub-id pub-id-type="pmid">35463381</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maringe</surname><given-names>C</given-names></name><name><surname>Spicer</surname><given-names>J</given-names></name><name><surname>Morris</surname><given-names>M</given-names></name><name><surname>Purushotham</surname><given-names>A</given-names></name><name><surname>Nolte</surname><given-names>E</given-names></name><name><surname>Sullivan</surname><given-names>R</given-names></name><name><surname>Rachet</surname><given-names>B</given-names></name><name><surname>Aggarwal</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study</article-title><source>The Lancet. Oncology</source><volume>21</volume><fpage>1023</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(20)30388-0</pub-id><pub-id pub-id-type="pmid">32702310</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayo</surname><given-names>M</given-names></name><name><surname>Potugari</surname><given-names>B</given-names></name><name><surname>Bzeih</surname><given-names>R</given-names></name><name><surname>Scheidel</surname><given-names>C</given-names></name><name><surname>Carrera</surname><given-names>C</given-names></name><name><surname>Shellenberger</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cancer screening during the COVID-19 pandemic: a systematic review and meta-analysis</article-title><source>Mayo Clinic Proceedings. Innovations, Quality &amp; Outcomes</source><volume>5</volume><fpage>1109</fpage><lpage>1117</lpage><pub-id pub-id-type="doi">10.1016/j.mayocpiqo.2021.10.003</pub-id><pub-id pub-id-type="pmid">34693211</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazidimoradi</surname><given-names>A</given-names></name><name><surname>Hadavandsiri</surname><given-names>F</given-names></name><name><surname>Momenimovahed</surname><given-names>Z</given-names></name><name><surname>Salehiniya</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Impact of the COVID-19 pandemic on colorectal cancer diagnosis and treatment: a systematic review</article-title><source>Journal of Gastrointestinal Cancer</source><volume>2021</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1007/s12029-021-00752-5</pub-id><pub-id pub-id-type="pmid">34843058</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazidimoradi</surname><given-names>A</given-names></name><name><surname>Tiznobaik</surname><given-names>A</given-names></name><name><surname>Salehiniya</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Impact of the COVID-19 pandemic on colorectal cancer screening: a systematic review</article-title><source>Journal of Gastrointestinal Cancer</source><volume>53</volume><fpage>730</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1007/s12029-021-00679-x</pub-id><pub-id pub-id-type="pmid">34406626</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Momenimovahed</surname><given-names>Z</given-names></name><name><surname>Salehiniya</surname><given-names>H</given-names></name><name><surname>Hadavandsiri</surname><given-names>F</given-names></name><name><surname>Allahqoli</surname><given-names>L</given-names></name><name><surname>Günther</surname><given-names>V</given-names></name><name><surname>Alkatout</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Psychological distress among cancer patients during COVID-19 pandemic in the world: A systematic review</article-title><source>Frontiers in Psychology</source><volume>12</volume><elocation-id>682154</elocation-id><pub-id pub-id-type="doi">10.3389/fpsyg.2021.682154</pub-id><pub-id pub-id-type="pmid">34650469</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mostafaei</surname><given-names>A</given-names></name><name><surname>Sadeghi-Ghyassi</surname><given-names>F</given-names></name><name><surname>Kabiri</surname><given-names>N</given-names></name><name><surname>Hajebrahimi</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Experiences of patients and providers while using telemedicine in cancer care during COVID-19 pandemic: a systematic review and meta-synthesis of qualitative literature</article-title><source>Supportive Care in Cancer</source><volume>30</volume><fpage>10483</fpage><lpage>10494</lpage><pub-id pub-id-type="doi">10.1007/s00520-022-07415-6</pub-id><pub-id pub-id-type="pmid">36322247</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moujaess</surname><given-names>E</given-names></name><name><surname>Kourie</surname><given-names>HR</given-names></name><name><surname>Ghosn</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence</article-title><source>Critical Reviews in Oncology/Hematology</source><volume>150</volume><elocation-id>102972</elocation-id><pub-id pub-id-type="doi">10.1016/j.critrevonc.2020.102972</pub-id><pub-id pub-id-type="pmid">32344317</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muls</surname><given-names>A</given-names></name><name><surname>Georgopoulou</surname><given-names>S</given-names></name><name><surname>Hainsworth</surname><given-names>E</given-names></name><name><surname>Hartley</surname><given-names>B</given-names></name><name><surname>O’Gara</surname><given-names>G</given-names></name><name><surname>Stapleton</surname><given-names>S</given-names></name><name><surname>Cruickshank</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The psychosocial and emotional experiences of cancer patients during the COVID-19 pandemic: A systematic review</article-title><source>Seminars in Oncology</source><volume>49</volume><fpage>371</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1053/j.seminoncol.2022.08.001</pub-id><pub-id pub-id-type="pmid">36089413</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>A</given-names></name><name><surname>Kirby</surname><given-names>A</given-names></name><name><surname>Lawlor</surname><given-names>A</given-names></name><name><surname>Drummond</surname><given-names>FJ</given-names></name><name><surname>Heavin</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Mitigating the impact of the COVID-19 pandemic on adult cancer patients through telehealth adoption: a systematic review</article-title><source>Sensors</source><volume>22</volume><elocation-id>3598</elocation-id><pub-id pub-id-type="doi">10.3390/s22093598</pub-id><pub-id pub-id-type="pmid">35591287</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>JS</given-names></name><name><surname>Hamilton</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: a rapid review and meta-analysis</article-title><source>Journal of Medical Screening</source><volume>29</volume><fpage>209</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1177/09691413221101807</pub-id><pub-id pub-id-type="pmid">35593115</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolopoulos</surname><given-names>M</given-names></name><name><surname>Maheshwari</surname><given-names>MK</given-names></name><name><surname>Doumouchtsis</surname><given-names>SK</given-names></name><collab>CHORUS: An International Collaboration for Harmonising Outcomes, Research and Standards in Urogynaecology and Women’s Health</collab></person-group><year iso-8601-date="2022">2022</year><article-title>Impact of COVID-19 in gynaecological oncology care: a systematic rapid review</article-title><source>Archives of Gynecology and Obstetrics</source><volume>305</volume><fpage>555</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1007/s00404-021-06295-1</pub-id><pub-id pub-id-type="pmid">34729631</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacheco</surname><given-names>RL</given-names></name><name><surname>Martimbianco</surname><given-names>ALC</given-names></name><name><surname>Roitberg</surname><given-names>F</given-names></name><name><surname>Ilbawi</surname><given-names>A</given-names></name><name><surname>Riera</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Impact of strategies for mitigating delays and disruptions in cancer care due to COVID-19: systematic review</article-title><source>JCO Global Oncology</source><volume>7</volume><fpage>342</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1200/GO.20.00632</pub-id><pub-id pub-id-type="pmid">33656910</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pararas</surname><given-names>N</given-names></name><name><surname>Pikouli</surname><given-names>A</given-names></name><name><surname>Papaconstantinou</surname><given-names>D</given-names></name><name><surname>Bagias</surname><given-names>G</given-names></name><name><surname>Nastos</surname><given-names>C</given-names></name><name><surname>Pikoulis</surname><given-names>A</given-names></name><name><surname>Dellaportas</surname><given-names>D</given-names></name><name><surname>Lykoudis</surname><given-names>P</given-names></name><name><surname>Pikoulis</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Colorectal surgery in the COVID-19 era: a systematic review and meta-analysis</article-title><source>Cancers</source><volume>14</volume><elocation-id>1229</elocation-id><pub-id pub-id-type="doi">10.3390/cancers14051229</pub-id><pub-id pub-id-type="pmid">35267537</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascual</surname><given-names>JSG</given-names></name><name><surname>Ignacio</surname><given-names>KHD</given-names></name><name><surname>Castillo</surname><given-names>MRL</given-names></name><name><surname>Khu</surname><given-names>KJO</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Practice patterns in surgical neuro-oncology among low- and middle-income countries during the coronavirus disease 2019 pandemic: a scoping review and situational report from the philippines</article-title><source>World Neurosurgery</source><volume>159</volume><fpage>189</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.wneu.2021.12.020</pub-id><pub-id pub-id-type="pmid">34902600</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piras</surname><given-names>A</given-names></name><name><surname>Venuti</surname><given-names>V</given-names></name><name><surname>D’Aviero</surname><given-names>A</given-names></name><name><surname>Cusumano</surname><given-names>D</given-names></name><name><surname>Pergolizzi</surname><given-names>S</given-names></name><name><surname>Daidone</surname><given-names>A</given-names></name><name><surname>Boldrini</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Covid-19 and radiotherapy: a systematic review after 2 years of pandemic</article-title><source>Clinical and Translational Imaging</source><volume>10</volume><fpage>611</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1007/s40336-022-00513-9</pub-id><pub-id pub-id-type="pmid">35910079</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riera</surname><given-names>R</given-names></name><name><surname>Bagattini</surname><given-names>ÂM</given-names></name><name><surname>Pacheco</surname><given-names>RL</given-names></name><name><surname>Pachito</surname><given-names>DV</given-names></name><name><surname>Roitberg</surname><given-names>F</given-names></name><name><surname>Ilbawi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review</article-title><source>JCO Global Oncology</source><volume>7</volume><fpage>311</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1200/GO.20.00639</pub-id><pub-id pub-id-type="pmid">33617304</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohilla</surname><given-names>KK</given-names></name><name><surname>Kalyani</surname><given-names>CV</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Quality of life of people with cancer in the era of the COVID-19 pandemic in India: a systematic review</article-title><source>Clinical Practice and Epidemiology in Mental Health</source><volume>17</volume><fpage>280</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.2174/1745017902117010280</pub-id><pub-id pub-id-type="pmid">35444705</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salehi</surname><given-names>F</given-names></name><name><surname>Mashhadi</surname><given-names>L</given-names></name><name><surname>Khazeni</surname><given-names>K</given-names></name><name><surname>Ebrahimi</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Management of cancer patients in the COVID-19 crisis using telemedicine: a systematic review</article-title><source>Studies in Health Technology and Informatics</source><volume>299</volume><fpage>118</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.3233/SHTI220969</pub-id><pub-id pub-id-type="pmid">36325852</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarich</surname><given-names>P</given-names></name><name><surname>Cabasag</surname><given-names>CJ</given-names></name><name><surname>Liebermann</surname><given-names>E</given-names></name><name><surname>Vaneckova</surname><given-names>P</given-names></name><name><surname>Carle</surname><given-names>C</given-names></name><name><surname>Hughes</surname><given-names>S</given-names></name><name><surname>Egger</surname><given-names>S</given-names></name><name><surname>O’Connell</surname><given-names>DL</given-names></name><name><surname>Weber</surname><given-names>MF</given-names></name><name><surname>da Costa</surname><given-names>AM</given-names></name><name><surname>Caruana</surname><given-names>M</given-names></name><name><surname>Bray</surname><given-names>F</given-names></name><name><surname>Canfell</surname><given-names>K</given-names></name><name><surname>Ginsburg</surname><given-names>O</given-names></name><name><surname>Steinberg</surname><given-names>J</given-names></name><name><surname>Soerjomataram</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: a systematic review and meta-analysis</article-title><source>EClinicalMedicine</source><volume>47</volume><elocation-id>101375</elocation-id><pub-id pub-id-type="doi">10.1016/j.eclinm.2022.101375</pub-id><pub-id pub-id-type="pmid">35434579</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasidharanpillai</surname><given-names>S</given-names></name><name><surname>Ravishankar</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The short-term impact of COVID-19 pandemic on cervical cancer screening: a systematic review and meta-analysis</article-title><source>Asian Pacific Journal of Cancer Prevention</source><volume>23</volume><fpage>1497</fpage><lpage>1504</lpage><pub-id pub-id-type="doi">10.31557/APJCP.2022.23.5.1497</pub-id><pub-id pub-id-type="pmid">35633530</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shea</surname><given-names>BJ</given-names></name><name><surname>Reeves</surname><given-names>BC</given-names></name><name><surname>Wells</surname><given-names>G</given-names></name><name><surname>Thuku</surname><given-names>M</given-names></name><name><surname>Hamel</surname><given-names>C</given-names></name><name><surname>Moran</surname><given-names>J</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Tugwell</surname><given-names>P</given-names></name><name><surname>Welch</surname><given-names>V</given-names></name><name><surname>Kristjansson</surname><given-names>E</given-names></name><name><surname>Henry</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both</article-title><source>BMJ</source><volume>358</volume><elocation-id>j4008</elocation-id><pub-id pub-id-type="doi">10.1136/bmj.j4008</pub-id><pub-id pub-id-type="pmid">28935701</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>HG</given-names></name><name><surname>Jensen</surname><given-names>KK</given-names></name><name><surname>Jørgensen</surname><given-names>LN</given-names></name><name><surname>Krarup</surname><given-names>P-M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Impact of the COVID-19 pandemic on the management of colorectal cancer in Denmark</article-title><source>BJS Open</source><volume>5</volume><elocation-id>zrab108</elocation-id><pub-id pub-id-type="doi">10.1093/bjsopen/zrab108</pub-id><pub-id pub-id-type="pmid">34755189</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sozutek</surname><given-names>A</given-names></name><name><surname>Seker</surname><given-names>A</given-names></name><name><surname>Kuvvetli</surname><given-names>A</given-names></name><name><surname>Ozer</surname><given-names>N</given-names></name><name><surname>Genc</surname><given-names>IC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Evaluating the feasibility of performing elective gastrointestinal cancer surgery during the COVID-19 pandemic: an observational study with 60 days follow-up results of a tertiary referral pandemic Hospital</article-title><source>Journal of Surgical Oncology</source><volume>123</volume><fpage>834</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1002/jso.26396</pub-id><pub-id pub-id-type="pmid">33559133</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stang</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses</article-title><source>European Journal of Epidemiology</source><volume>25</volume><fpage>603</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1007/s10654-010-9491-z</pub-id><pub-id pub-id-type="pmid">20652370</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>P</given-names></name><name><surname>Luan</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Cao</surname><given-names>R</given-names></name><name><surname>Cai</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Breast reconstruction during the COVID-19 pandemic: a systematic review</article-title><source>Medicine</source><volume>100</volume><elocation-id>e26978</elocation-id><pub-id pub-id-type="doi">10.1097/MD.0000000000026978</pub-id><pub-id pub-id-type="pmid">34414973</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>G</given-names></name><name><surname>Pi</surname><given-names>F</given-names></name><name><surname>Tao</surname><given-names>J</given-names></name><name><surname>Wei</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Impact of the COVID-19 pandemic on surgical outcomes in patients undergoing colorectal cancer surgery: a retrospective study and meta-analysis of data from 11,082 participants</article-title><source>Frontiers in Public Health</source><volume>10</volume><elocation-id>907571</elocation-id><pub-id pub-id-type="doi">10.3389/fpubh.2022.907571</pub-id><pub-id pub-id-type="pmid">36249184</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teglia</surname><given-names>F</given-names></name><name><surname>Angelini</surname><given-names>M</given-names></name><name><surname>Astolfi</surname><given-names>L</given-names></name><name><surname>Casolari</surname><given-names>G</given-names></name><name><surname>Boffetta</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2022">2022a</year><article-title>Global association of COVID-19 pandemic measures with cancer screening: a systematic review and meta-analysis</article-title><source>JAMA Oncology</source><volume>8</volume><fpage>1287</fpage><lpage>1293</lpage><pub-id pub-id-type="doi">10.1001/jamaoncol.2022.2617</pub-id><pub-id pub-id-type="pmid">35797056</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teglia</surname><given-names>F</given-names></name><name><surname>Angelini</surname><given-names>M</given-names></name><name><surname>Casolari</surname><given-names>G</given-names></name><name><surname>Astolfi</surname><given-names>L</given-names></name><name><surname>Boffetta</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2022">2022b</year><article-title>Global association of COVID-19 pandemic measures with cancer treatment: a systematic review and meta-analysis</article-title><source>Cancers</source><volume>14</volume><elocation-id>5490</elocation-id><pub-id pub-id-type="doi">10.3390/cancers14225490</pub-id><pub-id pub-id-type="pmid">36428583</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>DJ</given-names></name><name><surname>Yom</surname><given-names>SS</given-names></name><name><surname>Saeed</surname><given-names>H</given-names></name><name><surname>El Naqa</surname><given-names>I</given-names></name><name><surname>Ballas</surname><given-names>L</given-names></name><name><surname>Bentzen</surname><given-names>SM</given-names></name><name><surname>Chao</surname><given-names>ST</given-names></name><name><surname>Choudhury</surname><given-names>A</given-names></name><name><surname>Coles</surname><given-names>CE</given-names></name><name><surname>Dover</surname><given-names>L</given-names></name><name><surname>Guadagnolo</surname><given-names>BA</given-names></name><name><surname>Guckenberger</surname><given-names>M</given-names></name><name><surname>Hoskin</surname><given-names>P</given-names></name><name><surname>Jabbour</surname><given-names>SK</given-names></name><name><surname>Katz</surname><given-names>MS</given-names></name><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Rembielak</surname><given-names>A</given-names></name><name><surname>Sebag-Montefiore</surname><given-names>D</given-names></name><name><surname>Sher</surname><given-names>DJ</given-names></name><name><surname>Terezakis</surname><given-names>SA</given-names></name><name><surname>Thomas</surname><given-names>TV</given-names></name><name><surname>Vogel</surname><given-names>J</given-names></name><name><surname>Estes</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Radiation fractionation schedules published during the COVID-19 pandemic: a systematic review of the quality of evidence and recommendations for future development</article-title><source>International Journal of Radiation Oncology, Biology, Physics</source><volume>108</volume><fpage>379</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1016/j.ijrobp.2020.06.054</pub-id><pub-id pub-id-type="pmid">32798063</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Venkatesulu</surname><given-names>BP</given-names></name><name><surname>Chandrasekar</surname><given-names>VT</given-names></name><name><surname>Girdhar</surname><given-names>P</given-names></name><name><surname>Advani</surname><given-names>P</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Elumalai</surname><given-names>T</given-names></name><name><surname>Hsieh</surname><given-names>C</given-names></name><name><surname>Elghazawy</surname><given-names>HI</given-names></name><name><surname>Verma</surname><given-names>V</given-names></name><name><surname>Krishnan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A systematic review and meta-analysis of cancer patients affected by a novel coronavirus</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2020.05.27.20115303</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vigliar</surname><given-names>E</given-names></name><name><surname>Cepurnaite</surname><given-names>R</given-names></name><name><surname>Alcaraz-Mateos</surname><given-names>E</given-names></name><name><surname>Ali</surname><given-names>SZ</given-names></name><name><surname>Baloch</surname><given-names>ZW</given-names></name><name><surname>Bellevicine</surname><given-names>C</given-names></name><name><surname>Bongiovanni</surname><given-names>M</given-names></name><name><surname>Botsun</surname><given-names>P</given-names></name><name><surname>Bruzzese</surname><given-names>D</given-names></name><name><surname>Bubendorf</surname><given-names>L</given-names></name><name><surname>Büttner</surname><given-names>R</given-names></name><name><surname>Canberk</surname><given-names>S</given-names></name><name><surname>Capitanio</surname><given-names>A</given-names></name><name><surname>Casadio</surname><given-names>C</given-names></name><name><surname>Cazacu</surname><given-names>E</given-names></name><name><surname>Cochand-Priollet</surname><given-names>B</given-names></name><name><surname>D’Amuri</surname><given-names>A</given-names></name><name><surname>Eloy</surname><given-names>C</given-names></name><name><surname>Engels</surname><given-names>M</given-names></name><name><surname>Fadda</surname><given-names>G</given-names></name><name><surname>Fontanini</surname><given-names>G</given-names></name><name><surname>Fulciniti</surname><given-names>F</given-names></name><name><surname>Hofman</surname><given-names>P</given-names></name><name><surname>Iaccarino</surname><given-names>A</given-names></name><name><surname>Ieni</surname><given-names>A</given-names></name><name><surname>Jiang</surname><given-names>XS</given-names></name><name><surname>Kakudo</surname><given-names>K</given-names></name><name><surname>Kern</surname><given-names>I</given-names></name><name><surname>Kholova</surname><given-names>I</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Lobo</surname><given-names>A</given-names></name><name><surname>Lozano</surname><given-names>MD</given-names></name><name><surname>Malapelle</surname><given-names>U</given-names></name><name><surname>Maleki</surname><given-names>Z</given-names></name><name><surname>Michelow</surname><given-names>P</given-names></name><name><surname>Musayev</surname><given-names>J</given-names></name><name><surname>Özgün</surname><given-names>G</given-names></name><name><surname>Oznur</surname><given-names>M</given-names></name><name><surname>Peiró Marqués</surname><given-names>FM</given-names></name><name><surname>Pisapia</surname><given-names>P</given-names></name><name><surname>Poller</surname><given-names>D</given-names></name><name><surname>Pyzlak</surname><given-names>M</given-names></name><name><surname>Robinson</surname><given-names>B</given-names></name><name><surname>Rossi</surname><given-names>ED</given-names></name><name><surname>Roy-Chowdhuri</surname><given-names>S</given-names></name><name><surname>Saieg</surname><given-names>M</given-names></name><name><surname>Savic Prince</surname><given-names>S</given-names></name><name><surname>Schmitt</surname><given-names>FC</given-names></name><name><surname>Javier Seguí Iváñez</surname><given-names>F</given-names></name><name><surname>Štoos-Veić</surname><given-names>T</given-names></name><name><surname>Sulaieva</surname><given-names>O</given-names></name><name><surname>Sweeney</surname><given-names>BJ</given-names></name><name><surname>Tuccari</surname><given-names>G</given-names></name><name><surname>van Velthuysen</surname><given-names>M-L</given-names></name><name><surname>VanderLaan</surname><given-names>PA</given-names></name><name><surname>Vielh</surname><given-names>P</given-names></name><name><surname>Viola</surname><given-names>P</given-names></name><name><surname>Voorham</surname><given-names>R</given-names></name><name><surname>Weynand</surname><given-names>B</given-names></name><name><surname>Zeppa</surname><given-names>P</given-names></name><name><surname>Faquin</surname><given-names>WC</given-names></name><name><surname>Pitman</surname><given-names>MB</given-names></name><name><surname>Troncone</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Global impact of the COVID-19 pandemic on cytopathology practice: results from an international survey of laboratories in 23 countries</article-title><source>Cancer Cytopathology</source><volume>128</volume><fpage>885</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1002/cncy.22373</pub-id><pub-id pub-id-type="pmid">33108683</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whittaker</surname><given-names>TM</given-names></name><name><surname>Abdelrazek</surname><given-names>MEG</given-names></name><name><surname>Fitzpatrick</surname><given-names>AJ</given-names></name><name><surname>Froud</surname><given-names>JLJ</given-names></name><name><surname>Kelly</surname><given-names>JR</given-names></name><name><surname>Williamson</surname><given-names>JS</given-names></name><name><surname>Williams</surname><given-names>GL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Delay to elective colorectal cancer surgery and implications for survival: a systematic review and meta-analysis</article-title><source>Colorectal Disease</source><volume>23</volume><fpage>1699</fpage><lpage>1711</lpage><pub-id pub-id-type="doi">10.1111/codi.15625</pub-id><pub-id pub-id-type="pmid">33714235</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>MC</given-names></name><name><surname>Shaw</surname><given-names>L</given-names></name><name><surname>Hirschfeld</surname><given-names>CB</given-names></name><name><surname>Maurovich-Horvat</surname><given-names>P</given-names></name><name><surname>Nørgaard</surname><given-names>BL</given-names></name><name><surname>Pontone</surname><given-names>G</given-names></name><name><surname>Jimenez-Heffernan</surname><given-names>A</given-names></name><name><surname>Sinitsyn</surname><given-names>V</given-names></name><name><surname>Sergienko</surname><given-names>V</given-names></name><name><surname>Ansheles</surname><given-names>A</given-names></name><name><surname>Bax</surname><given-names>JJ</given-names></name><name><surname>Buechel</surname><given-names>R</given-names></name><name><surname>Milan</surname><given-names>E</given-names></name><name><surname>Slart</surname><given-names>RHJA</given-names></name><name><surname>Nicol</surname><given-names>E</given-names></name><name><surname>Bucciarelli-Ducci</surname><given-names>C</given-names></name><name><surname>Pynda</surname><given-names>Y</given-names></name><name><surname>Better</surname><given-names>N</given-names></name><name><surname>Cerci</surname><given-names>R</given-names></name><name><surname>Dorbala</surname><given-names>S</given-names></name><name><surname>Raggi</surname><given-names>P</given-names></name><name><surname>Villines</surname><given-names>TC</given-names></name><name><surname>Vitola</surname><given-names>J</given-names></name><name><surname>Malkovskiy</surname><given-names>E</given-names></name><name><surname>Goebel</surname><given-names>B</given-names></name><name><surname>Cohen</surname><given-names>Y</given-names></name><name><surname>Randazzo</surname><given-names>M</given-names></name><name><surname>Pascual</surname><given-names>TNB</given-names></name><name><surname>Dondi</surname><given-names>M</given-names></name><name><surname>Paez</surname><given-names>D</given-names></name><name><surname>Einstein</surname><given-names>AJ</given-names></name><collab>INCAPS COVID Investigators Group</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe</article-title><source>Open Heart</source><volume>8</volume><elocation-id>e001681</elocation-id><pub-id pub-id-type="doi">10.1136/openhrt-2021-001681</pub-id><pub-id pub-id-type="pmid">34353958</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zapała</surname><given-names>J</given-names></name><name><surname>Matecka</surname><given-names>M</given-names></name><name><surname>Zok</surname><given-names>A</given-names></name><name><surname>Baum</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The needs of cancer patients during the COVID-19 pandemic-psychosocial, ethical and spiritual aspects-systematic review</article-title><source>PeerJ</source><volume>10</volume><elocation-id>e13480</elocation-id><pub-id pub-id-type="doi">10.7717/peerj.13480</pub-id><pub-id pub-id-type="pmid">35789657</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Tong</surname><given-names>F</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Wen</surname><given-names>M</given-names></name><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Yi</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The prevalence of psychological disorders among cancer patients during the COVID-19 pandemic: a meta-analysis</article-title><source>Psycho-Oncology</source><volume>31</volume><fpage>1972</fpage><lpage>1987</lpage><pub-id pub-id-type="doi">10.1002/pon.6012</pub-id><pub-id pub-id-type="pmid">35950545</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85679.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Malagón</surname><given-names>Talía</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap><country>Canada</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.12.18.22283642" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.12.18.22283642"/></front-stub><body><p>This solid work reviews and synthesizes evidence of the impact of the COVID-19 pandemic on a variety of cancer outcomes. The results have potentially important implications for various fields of cancer research as they review evidence spanning from cancer prevention efforts to changes in diagnoses and cancer treatment modalities.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85679.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Malagón</surname><given-names>Talía</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>McGill University</institution></institution-wrap><country>Canada</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Kabiri</surname><given-names>Neda</given-names></name><role>Reviewer</role><aff><institution/><country>Islamic Republic of Iran</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.12.18.22283642">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2022.12.18.22283642v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Changes in cancer prevention and management and patient needs during the COVID-19 pandemic: An umbrella review of systematic reviews&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by a Reviewing Editor and Eduardo Franco as the Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Neda Kabiri (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1. Clarify the objectives of the review.</p><p>2. Revise Table 3 to clarify column headings.</p><p>3. Address the searching of only one database as a major limitation of review.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>The review appears to me to be somewhat unfocused, and it is not clear to me how analyses and extracted data align with the authors' objectives. I think this could be improved by the following:</p><p>– In the introduction, the authors could more clearly state why an umbrella review is needed now, and what an umbrella review can teach us that individual systematic reviews cannot, i.e. what they hope to learn.</p><p>– The objective of &quot;synthesis&quot; is very vague. I would suggest listing more specific objectives for the umbrella review so the reader can better assess the authors' interests (ex. assess the quality of systematic reviews of COVID-19 impact, assess the geographical breadth of the available evidence, summarize conclusions from different reviews, assess evidence gaps, etc.)</p><p>– Explain how the extracted data relates to the above objective(s), and how the analyses performed relate to the above objective(s).</p><p>– Structure the results and Discussion section in line with the above objective(s).</p><p>The inclusion of various health outcomes of interest is laudable but makes it more challenging to present a coherent picture across different outcomes as very little space is dedicated to each. This is a suggestion, but I think this could potentially be improved by separating out the studies into different tables stratified by the outcome and presented in their relevant section in the results, rather than combining all studies into larger tables mixing very different outcomes.</p><p>Tables are over-reliant on acronyms. While I understand space is always an issue in tables, they would be much more readable if fewer acronyms were used. If keeping acronyms, please check legends as acronyms were not always defined.</p><p>Table 3 is not self-sufficient as readers do not know the topic of each question in AMSTAR-2, so the table is uninformative without a copy of the tool. The authors may want to consider defining questions in the footnotes or providing short titles to questions rather than numbers.</p><p>Systematic reviews of HPV vaccination and tobacco cessation do not appear to fit the eligibility criteria, where the target population is defined as &quot;included individuals diagnosed with any type of cancer and at any cancer stages (early to advanced), or individuals targeted for cancer screening&quot;. Please revise.</p><p>The protocol registry the authors have used appears to be more adapted to observational studies than reviews. In the future, the authors may want to consider using registries that are more suited to review protocols (ex. PROSPERO).</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>I appreciate the effort by the authors to conduct an umbrella review for assessing the Changes in cancer prevention and management and patient needs during the COVID-19 pandemic. While the findings are very important, I believe they will be best served with major revisions to the manuscript prior to publication.</p><p>The title does not reflect what you have done in your review. In my idea 'the impact of COVID-19 on cancer care' which you have mentioned in the objective is better.</p><p>Line 26: how you quantified the impact of …? As you had a descriptive analysis.</p><p>As a habit, we need to avoid the language construct of &quot;cancer patients&quot; (many places in the manuscript); patients don't want to be defined as people by their illness. Better to say &quot;patients with cancer&quot;. Line 35: forty five.</p><p>Line 288: only appraises?</p><p>What is your final conclusion? Explain it more in detail.</p><p>Figure 1. You have mentioned 'no English language' as a reason for the exclusion of one study. Since you had &quot;No language restriction was applied.&quot; In the methods.</p><p>Appendix 2 search strategy: did not you use any MeSH terms? How about synonyms for 'cancer'? as you have included a meta-synthesis in your review, was not it better to include this word in the search strategy? And did you use (systematic review OR meta-analysis) as a keyword to search or as a filter in PubMed search? Although you have conducted your search, was it enough to search only one database? What was the logic behind it? Which you have mentioned this as a major limitation of your study.</p><p>There is no need for appendix 5 since the data is repeatedly presented in appendix 3.</p><p>You can merge appendices 6-13 in one.</p><p>A careful review of English language usage and grammar is required before publication.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85679.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>The review appears to me to be somewhat unfocused, and it is not clear to me how analyses and extracted data align with the authors' objectives. I think this could be improved by the following:</p><p>– In the introduction, the authors could more clearly state why an umbrella review is needed now, and what an umbrella review can teach us that individual systematic reviews cannot, i.e. what they hope to learn.</p></disp-quote><p>We agree with the reviewer that this is an important aspect to clarify. We have now revised the introduction to address the need of doing an umbrella review.</p><p>“While several systematic reviews have examined the impact of COVID-19 on cancer care, they evaluated different outcomes and periods of the pandemic, and thus the available review findings are rather fragmented 3 4 8-14. A comprehensive review of impact of COVID-19 on several aspects of cancer would be essential to understand gaps and scale-up evidence-based interventions, including learning lessons for future pandemics. In addition, although systematic reviews are important for public health and policy decision-making during the pandemic, the level of methodological rigor they implemented is unclear.”</p><disp-quote content-type="editor-comment"><p>– The objective of &quot;synthesis&quot; is very vague. I would suggest listing more specific objectives for the umbrella review so the reader can better assess the authors' interests (ex. assess the quality of systematic reviews of COVID-19 impact, assess the geographical breadth of the available evidence, summarize conclusions from different reviews, assess evidence gaps, etc.)</p></disp-quote><p>We share the reviewer’s concerns. We have now revised the aim to clarify the objectives of the umbrella review.</p><p>“In the current study we performed an umbrella review of systematic reviews to summarize the impact of COVID-19 on several aspects of cancer care, including treatment, diagnosis, financial, psychological and social dimensions. We assessed the amount and geographical breadth of the available evidence and methodological rigor of the primary studies included in each review (as assessed by the reviewers) and of the systematic reviews themselves; and summarized the conclusions from different reviews on COVID-19 impact.”</p><disp-quote content-type="editor-comment"><p>– Explain how the extracted data relates to the above objective(s), and how the analyses performed relate to the above objective(s).</p></disp-quote><p>We followed the reviewer’s suggestion and now organized the data extraction section according to our objectives, and provided information on how such information was extracted and analyzed in the analysis section.</p><p>“The data extraction was performed by one of the authors and the extracted data were further checked by two other authors; differences were settled by discussion. In case an eligible article included data from several diseases, when feasible, we extracted information only on cancer-related outcomes of our interest. First, we extracted general information from the eligible reviews, including information on authors, year of publication, type of studies considered (design), number of eligible studies, COVID-19 period covered (until when), whether it has considered studies with pre-pandemic controls (yes exclusively/yes for some/not at all), the outcomes examined and for which cancers each outcome was examined, and methods of analysis and heterogeneity (if provided). To provide the geographical breadth of the evidence, we extracted information on location(s) of the individual studies included in the eligible reviews; for example, retrieving information on countries and areas or whether the studies were done in multiple countries. Concerning the methodological rigor, for each systematic review we extracted information on whether the authors used any previously validated tool or any other set of extracted items to assess the methodological rigor of the included studies. If yes, we recorded the tool used and the main conclusions of the assessment were grouped in the broad categories: most studies were weak in methodological rigor, most studies were strong in methodological rigor, or mixed/ intermediate pattern between the other two categories. Two reviewers assessed methodological rigor of the included systematic reviews using the AMSTAR-2 tool17; any discrepancies were settled with the help of a third reviewer. AMSTAR-2 is based on a 16 item or domain checklist, with seven of these items considered critical for the overall validity of a review. The domains considered critical are: (i) protocol registration before starting the review; (ii) adequate and comprehensive search of the literature; (iii) providing justification for the exclusion of individual studies; (iv) risk of bias assessment of the studies included in the review; (v) use of appropriate statistical methods in performing a meta-analysis; (vi) accounting for risk of bias when interpreting the results; (vii) and evaluation of the presence and impact of publication bias. Last, based on abstract and full text reading, we extracted information on main conclusions derived from each of the included reviews. When the review included several disease areas, we extracted information on main findings of the included individual studies within the review that were relevant to cancer.”</p><p>“Due to high heterogeneity in the designs, study questions, outcomes, and metrics, a descriptive analysis was performed. We calculated the proportion of reviews that provided information on single countries and multiple countries. Median and interquartile range were calculated for some of the characteristics of the eligible reviews (e.g., number of databases searched). Separate tables were created for the methodological appraisal of the systematic reviews, the methodological appraisal of the studies in each systematic review, for the characteristics and subject matter information of each systematic review, and for the final conclusions of each systematic review. In addition, we created a separate table for reviews that implemented meta-analysis, providing the summary estimates, 95% confidence intervals and heterogeneity estimates. Limitations and areas of limited evidence were noted.”</p><disp-quote content-type="editor-comment"><p>– Structure the results and Discussion section in line with the above objective(s).</p></disp-quote><p>The result section reflects now with the revised objectives. In the discussion we have put more emphasizes on main findings related to COVID-19 impact on cancer care, as well as recognized the limitations that come from little representations of data from low and middle income countries, as well as from the low quality of evidence.</p><disp-quote content-type="editor-comment"><p>The inclusion of various health outcomes of interest is laudable but makes it more challenging to present a coherent picture across different outcomes as very little space is dedicated to each. This is a suggestion, but I think this could potentially be improved by separating out the studies into different tables stratified by the outcome and presented in their relevant section in the results, rather than combining all studies into larger tables mixing very different outcomes.</p></disp-quote><p>We agree with the reviewer that data presentation is challenging when dealing with different outcomes. However, for the main text, we compressed the information to provide a general information, but in the supplemental material we provide separate tables for each outcome.</p><disp-quote content-type="editor-comment"><p>Tables are over-reliant on acronyms. While I understand space is always an issue in tables, they would be much more readable if fewer acronyms were used. If keeping acronyms, please check legends as acronyms were not always defined.</p></disp-quote><p>Due to various outcomes and data we included, we tried to condense the information in main tables to provide as much as information as possible. We now revised the legends, so all acronyms are defined and are easy to read.</p><disp-quote content-type="editor-comment"><p>Table 3 is not self-sufficient as readers do not know the topic of each question in AMSTAR-2, so the table is uninformative without a copy of the tool. The authors may want to consider defining questions in the footnotes or providing short titles to questions rather than numbers.</p></disp-quote><p>Thank you for the excellent feedback. We have now added the questions in the Footnote.</p><disp-quote content-type="editor-comment"><p>Systematic reviews of HPV vaccination and tobacco cessation do not appear to fit the eligibility criteria, where the target population is defined as &quot;included individuals diagnosed with any type of cancer and at any cancer stages (early to advanced), or individuals targeted for cancer screening&quot;. Please revise.</p></disp-quote><p>We share the reviewer`s concern. We have now clarified this aspect of inclusion criteria.</p><p>“In addition, irrespective of including patients with cancer, we included reviews that looked at impact of COVID-19 on uptake of HPV vaccination and tobacco use and cessation.”</p><disp-quote content-type="editor-comment"><p>The protocol registry the authors have used appears to be more adapted to observational studies than reviews. In the future, the authors may want to consider using registries that are more suited to review protocols (ex. PROSPERO).</p></disp-quote><p>We thank the reviewer for the suggestion. We will make sure next time we submit in a register that is more suitable to review protocols.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>I appreciate the effort by the authors to conduct an umbrella review for assessing the Changes in cancer prevention and management and patient needs during the COVID-19 pandemic. While the findings are very important, I believe they will be best served with major revisions to the manuscript prior to publication.</p><p>The title does not reflect what you have done in your review. In my idea 'the impact of COVID-19 on cancer care' which you have mentioned in the objective is better.</p></disp-quote><p>We followed the reviewer’s suggestion and revised the title as following “The impact of the COVID-19 pandemic on cancer prevention and management, and patient needs: An umbrella review of systematic reviews”.</p><disp-quote content-type="editor-comment"><p>Line 26: how you quantified the impact of …? As you had a descriptive analysis.</p></disp-quote><p>This is an important point to clarify. As highlighted in the paper, we have extracted also information on reviews that performed meta-analysis and compared data with pre-pandemic period. We have now added this aspect in the statistical analysis.</p><p>“In addition, we created a separate table for reviews that implemented meta-analysis, providing the summary estimates, 95% confidence intervals and heterogeneity estimates. Limitations and areas of limited evidence were noted.”</p><disp-quote content-type="editor-comment"><p>As a habit, we need to avoid the language construct of &quot;cancer patients&quot; (many places in the manuscript); patients don't want to be defined as people by their illness. Better to say &quot;patients with cancer&quot;. Line 35: forty five.</p></disp-quote><p>We agree with the reviewer. We have now revised throughout the manuscript.</p><disp-quote content-type="editor-comment"><p>Line 288: only appraises?</p></disp-quote><p>We revised the sentence to also add “summarize”.</p><p>“The current umbrella review summarized and appraised systematically the evidence on the extent to which several aspects of cancer care were disrupted during the COVID-19 pandemic”</p><disp-quote content-type="editor-comment"><p>What is your final conclusion? Explain it more in detail.</p></disp-quote><p>We revised the conclusion as following:</p><p>“In summary, evidence shows a diverse and substantial impact of the COVID-19 pandemic on cancer care, including delays in treatment, screening and diagnosis. Also, patients with cancer had been affected psychologically, socially, and financially during the COVID-19 crisis. However, large uncertainty and gaps exist in the literature on this topic. Most of the evidence on the topic is derived mainly from high and middle-income countries, and low-quality studies, and thus, future high-quality studies with larger geographical capture and properly performed, rigorous systematic reviews with careful meta-analyses will continue to have value in this field.”</p><disp-quote content-type="editor-comment"><p>Figure 1. You have mentioned 'no English language' as a reason for the exclusion of one study. Since you had &quot;No language restriction was applied.&quot; In the methods.</p></disp-quote><p>We clarified this issue in the footnote of the figure.</p><p>“In the search, we did not include any language restriction filter. However, during full text screening we included only studies that were in English.”</p><disp-quote content-type="editor-comment"><p>Appendix 2 search strategy: did not you use any MeSH terms? How about synonyms for 'cancer'? as you have included a meta-synthesis in your review, was not it better to include this word in the search strategy? And did you use (systematic review OR meta-analysis) as a keyword to search or as a filter in PubMed search? Although you have conducted your search, was it enough to search only one database? What was the logic behind it? Which you have mentioned this as a major limitation of your study.</p></disp-quote><p>We agree with the reviewer’s remarks and suggestions. As clarified in our response to the first comment, we addressed this issue by having the search strategy designed for a specialized librarian. We now consider our approach as a strength of our study.</p><disp-quote content-type="editor-comment"><p>There is no need for appendix 5 since the data is repeatedly presented in appendix 3.</p></disp-quote><p>We share the reviewer`s concern. However, we added Appendiy 5 to have a better representation of data (derived from Appendix 3) on methodological rigor. Therefore, we decided to keep the table.</p><disp-quote content-type="editor-comment"><p>You can merge appendices 6-13 in one.</p></disp-quote><p>Mering appendices 6-13 could be a good idea. However, since there were different outcomes, it could be easier to read and follow having separate tables for each outcome.</p><disp-quote content-type="editor-comment"><p>A careful review of English language usage and grammar is required before publication.</p></disp-quote><p>We have now revised the manuscript throughout for English language.</p></body></sub-article></article>